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ABSTRACT
The effects of desmopressin acetate (DDAVP), a vasopressin 
analog, were investigated using a computerized task designed to 
measure speed of accessing long-term memory at three levels of 
processing (physically identical decisions, same name decisions and 
same category decisions), and an unexpected free recall of the words 
presented. Forty-one healthy females and forty-three healthy 
males (age 18-34) intranasally received either 60 ug DDAVP in 0.6 
ml of solution or 0.6 ml of saline 20 minutes prior to testing.
DDAVP did not affect response time on the computerized task; 
however, when response time control trials were subtracted from 
the corresponding cells of the design, DDAVP was found to decrease 
response times for physically identical decisions only. In addition, 
DDAVP increased response times on the response time control task 
designed to measure the motor component of responding. Analysis of 
the error rates suggests a subtle sexually dimorphic effect of the 
peptide in that DDAVP facilitated accuracy for DDAVP-treated 
female subjects, but had an adverse effect in regard to error rates 
for DDAVP-treated male subjects. No treatment effect was found 
for incidental learning as measured by unexpected free recall of the 
words presented during the computer task.
CHAPTER I
INTRODUCTION
Vasopressin is a nonapeptide hormone synthesized in the 
suprachiasmatic, paraventricular and supraoptic nuclei of the 
hypothalamus. The peptide is cyclic with a disulfide bridge between 
positions one and six. From the hypothalamic nuclei, the peptide is 
transported via axons to the neurohypophysis where it is released 
into the general circulation. Peripherally, vasopressin functions as 
a classical hormone. The hormonal functions of vasopressin include: 
regulation of osmolality, blood pressure, and blood volume (Hadley, 
1988). In addition to its effects as a classical hormone, vasopressin 
is believed to act as a neurotransmitter or neuromodulator within 
the central nervous system. Exohypothalamic fibers terminating in 
various brain areas have been localized in rodents (Boer & Swaab, 
1983), and it is at brain sites such as the hippocampus that 
vasopressin may implement its behavioral effects (Smock, Albeck & 
McMechen, 1990). One of the most studied behavioral effects of 
vasopressin is its effect on memory (van Wimersma Greidanus, van 
Ree & de Wied, 1983). Research exploring the effects of vasopressin 
on memory has employed both non-human and human subjects.
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The literature utilizing animal models has included studies of 
the organizational and activational effects of vasopressin on 
memory. The term "organizational" refers to the fact that 
administration of the peptide occurs during critical periods of cell 
proliferation in the brain. Rats exposed to vasopressin during the 
prenatal and neonatal periods demonstrate subsequent alterations in 
learning when trained and tested as adults, presumably by altering 
the brain systems which modulate memory (Ermisch, Koch & Barth, 
1986; Tinius, Beckwith, Preussler & Lee, 1987; Chen, Chen, Liu & Du, 
1988; Swenson, Beckwith, Lamberty, Krebs & Tinius, 1990).
Activational studies include all studies in which 
administration of the peptide occurs when the animal is mature and 
the brain fully developed. Vasopressin administration has been 
found to increase resistance to extinction of both passive and active 
avoidance tasks in the adult male rat (Ader & de Wied, 1972; de Wied 
& Versteeg, 1979), and to reactivate memory after amnestic 
treatments (Tinius, Beckwith, Wagner, Tinius & Traynor, 1986).
These findings have been viewed as evidence that vasopressin 
facilitates memory. Vasopressin administration has also been found 
to facilitate reversal learning of a black/white discrimination 
(Beckwith & Tinius, 1985; Beckwith, Tinius & Miller, 1987). This 
has been interpreted as evidence that vasopressin enhanced 
selective attention. In summary, the results of both activational 
studies and organizational studies involving animal models suggest 
that administration of vasopressin modulates memory as well as
3
attentional processes. Note that these are not independent 
processes.
Results of studies utilizing these animal models have led 
researchers to explore the actions of vasopressin or one of its 
several available analogs (see Table 1) on memory in healthy young 
adults using several information processing paradigms. Various 
memory tasks have been employed to assess the effects of 
vasopressin administration on visual memory, auditory memory, 
tactile memory, story reproduction, recall of prose and lists of 
words.
Beckwith, Petros, Kanaan-Beckwith, Couk, Haug and Ryan 
(1982) assessed the effects of vasopressin on visual memory using a 
modification of the Benton Visual Retention Test. Sixty micrograms 
(ug) of Desmopressin acetate (DDAVP) was intranasally 
administered to 39 healthy, young, adult male subjects (age 18-25).
A third group of 15 subjects received no treatment. The interval 
between administration of DDAVP and the memory test was 
approximately 25 minutes. Treatment did not affect measures of 
visual retention.
Snel, Taylor and Wegman (1987) studied the effects of 
vasopressin on both visual and auditory memory. Twenty male 
volunteers ranging from 20 to 31 years of age received either 
increasing daily doses of Desglycinamide-arginine-vasopressin 
(DGAVP) (0.1,0.3, 1.0, 3.0 and 10 mg) or a placebo for five 
consecutive days. Treatment was administered through two puffs of
4
Table 1
Amino Acid Sequence of Vasopressin and Vasopressin Analogs
AVP H -C ys-Tyr-Phe-G ln-Asn-C ys-Pro-l-A rg-G ly-N H2
Arginine Vasopressin
LVP H -C ys-Tyr-Phe-G ln-Asn-C ys-Pro-Lys-G ly-N H2
Lysine Vasopressin
DDAVP desam ino-C ys-Tyr-Phe-G ln-Asn-C ys-Pro-LArg-G ly-NH2
Desmopressin Acetate






TGLVP N-alpha-g lycy l-g lycy l-g lycy I-
Cys-Tyr-Phe-G ln-Asn-C ys-Pro-Lys-G ly-N H2
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nasal spray. The interval between administration of DGAVP and the 
tests of auditory and visual memory ranged from 51 to 111 minutes. 
There were no effects of treatment on the Visual Memory Test 
(VMT). Buschke's Selective Reminding Method was employed to 
assess the effects of vasopressin administration on auditory 
memory. Again, no effects of treatment were found.
The Tactile Memory Test has also been used to explore the 
effects of vasopressin on human memory (Posmurova, Alda, Plavka, 
Filip & Karen, 1983). Eighteen male and 18 female volunteers, 
ranging from 20-25 years of age, each participated in three 
experimental sessions; the minimum interval between two 
experimental sessions was 10 days. Each subject received a 
sequence of three single-dose treatments (8 ug of DDAVP, 100 ug of 
TGLVP and saline); one treatment was intramuscularly administered 
per experimental session. The sequence of administration was 
according to a predetermined Latin square design. The Tactile 
Memory Test was administered 95 minutes following each 
treatment. DDAVP significantly increased the mean score on the 
Tactile Memory Test. TGLVP had no influence on memory for this 
task. The authors also assessed the effects of vasopressin 
administration on performance of a Picture Recognition Test, a 
Story Reproduction Test and a Topographical Memory Test. Only the 
Story Reproduction Test yielded a significant treatment effect.
TGLVP increased the number of logical units remembered during both 
immediate and delayed recall (3.5 hours following treatment). The
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mean number of logical units remembered during immediate and 
delayed recall did not significantly differ following administration 
of TGLVP or saline; however, DDAVP decreased delayed recall when 
compared to immediate recall.
Several studies employed free recall of lists of words in an 
attempt to assess the effects of various vasopressin analogs on 
memory. Twenty male volunteers (mean age 24) participated in a 
study reported by Fehm-Wolfsdorf, Voigt & Fehm (1983). Twenty 
lists of 15 common German words were acoustically presented to 
the subjects (1 item/second) under instructions of "immediate free 
recall," followed by twenty additional lists under instructions of 
"delayed free recall." Following presentation of each of the latter 
20 lists, a 30 second delay period ensued during which a shadowing- 
task was employed; subjects were instructed to repeat a random 
series of digits aloud upon presentation. The initial treatment 
occurred at the end of the first experimental session. Subjects 
intranasally instilled one puff of LVP (10 I.U.) or a placebo. Subjects 
were further instructed to self-administer a similar dose for three 
consecutive days. Three days following the first session, subjects 
were again confronted with the immediate and delayed free recall 
situations. In addition, subjects were unexpectedly asked to write 
down as many words from all the lists as they could recall (final 
free recall). Treatment with LVP prolonged the primacy effect, 
while treatment with the placebo enhanced the recency effect during
7
immediate recall. Results of the delayed and final free recall 
measures did not yield significant effects of treatment.
In a study of the effects of LVP and oxytocin (a neuropeptide 
similar to vasopressin in molecular structure) on memory, Fehm- 
Wolfsdorf, Born, Voigt and Fehm (1984) employed an immediate and 
a final free recall. Following pretraining, thirty young, male 
volunteers (mean age 24) were acoustically presented with ten lists 
of common German monosyllabic words at a rate of 1 item/2 
seconds. Following the first session, subjects were treated with 
two puffs of intranasal spray, which contained 10 I.U. LVP, OXT or 
placebo. Subjects received a similar treatment 24 hours prior and 
one hour prior to the second session. The second session was 
scheduled one week after the initial session. During the second 
session, subjects were exposed to the original ten lists of words, as 
well as ten new lists of words. Following both sessions, subjects 
were asked to recall as many words as possible. Following the 
second session, subjects were unexpectedly asked to recall words 
from all previous lists. Treatment with LVP did not influence the 
number of words remembered correctly on both the immediate and 
final free recall tasks; whereas treatment with OXT impaired recall.
Pietrowsky, Fehm-Wolfsdorf, Born and Fehm (1988) instructed 
13 healthy male volunteers (mean age 24.3) to intranasally self- 
administer either 1 mg DGAVP or placebo. Administration occurred 
48, 24 and 1 hour prior to the subject's appearing at the laboratory, 
however the memory test did not occur until 3 hours following the
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most recent treatment. Each subject participated in two 
experimental sessions resulting in a within-subject cross-over 
design. The order of treatments was counterbalanced across 
subjects. All experimental sessions were at least one week apart. 
The authors employed the same list of words they used previously 
(i.e. Fehm-Wolfsdorf, et al., 1983; Fehm-Wolfsdorf, etal. 1984). 
Items were again presented at a rate of 1 item/2 seconds.
Following presentation of the words, subjects were asked to list as 
many words as they could remember irrespective of order (free- 
recall paradigm). Treatment with DGAVP significantly enhanced the 
recency effect and attenuated the primacy effect; however total 
number of words recalled was unaffected.
Weingartner, Gold, Ballenger, Smallberg, Summers, Rubinow, 
Post and Goodwin (1981) conducted a number of experiments in 
which they assessed the effect of DDAVP on memory in healthy 
young adults, as well as mood disordered individuals. In an 
experiment employing unimpaired subjects (4 males, 2 females), 30- 
60 ug of DDAVP was intranasally administered 3 times per day for 
2-3 weeks. Relative to baseline measures, DDAVP enhanced serial 
learning, prompted free recall and recall of semantically related 
words. DDAVP did not affect consistency of recall. A similar group 
of subjects treated with the vehicle solution for 8 weeks did not 
demonstrate any changes on the memory tasks.
Weingartner et al. (1981) also treated four mood-disordered 
female patients with DDAVP. Results are discussed relative to
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baseline measurements. The patients showed enhanced prompted 
free recall, recall of semantically related words, consistency of 
previously remembered words and organization of remembered 
words beginning 2 days after treatment onset and continuing for 2 
weeks. Treatment with DDAVP did not affect performance of a 
serial learning task. In an additional study, DDAVP was found to 
partially reverse the retrograde amnesia that follows 
electroconvulsive treatment.
Millar, Jeffcoate and Walder (1987) assessed the effects of 40 
ug of DDAVP on a short-term memory task, a semantic recognition 
task and a simple unprepared visual reaction time. In the same 
study the authors also explored the effects of DDAVP on alcohol- 
induced amnesia. Thirty-six male medical students were randomly 
divided into four groups (DDAVP plus alcohol, DDAVP plus placebo- 
alcohol, placebo-vasopressin plus alcohol and placebo-vasopressin 
plus placebo-alcohol). DDAVP was administered intranasally, and 
alcohol was administered as vodka at 2 ml per kilo body weight in an 
equal volume of fresh orange juice. After a 40 minute absorption 
period, subjects listened to 15 12-word lists presented at a rate of 
one word per 2 seconds. During a 20 second inter-list interval, 
subjects were instructed to recall as many words as possible from 
the previous list. Following completion of the short-term memory 
task, a semantic recognition task was implemented in which a 
category name and a test word were simultaneously presented on a 
VDU. Speed and accuracy of vocal binary decisions regarding
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category membership of the test word were recorded. One hundred 
and twenty trials were completed. Thirdly, subjects completed 30 
trials of a simple, unprepared visual reaction time task. Results 
indicated that DDAVP improved short-term memory performance of 
the placebo-alcohol and the alcohol groups when compared to 
placebo-vasopressin. DDAVP had no effect on the decision latencies 
associated with semantic recognition, and no effect on simple 
reaction time.
The subjects were asked to return to the laboratory 
approximately 24 hours later (K. Millar, personal communication, 
March 25, 1988). At this time subjects were asked to recall as 
many words as possible from the baseline and experimental sessions 
of the short-term memory trials. Subjects were then presented 
with the 30 category names employed in the semantic recognition 
task, and asked to recall as many test words as possible from both 
the baseline and experimental trials. Although treatment did not 
affect baseline recall, DDAVP impaired recall of experimental words 
from both the short-term memory tasks and the semantic 
recognition trials. The results suggest that while DDAVP enhanced 
short-term memory recall, the peptide impaired long-term memory 
recall. The authors discuss the results in terms of state dependent 
learning suggesting that DDAVP may produce a state of cognitive 
arousal.
In an attempt to better represent typical verbal learning 
processes of everyday situations, three published studies have
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assessed the effects of acute administration of DDAVP on sentence 
memory. Beckwith, Till and Schneider (1984) treated 64 male and 
64 female subjects (age 18-33) with 60 ug (i.n.) DDAVP or saline. 
Approximately 20 minutes following the treatment 16 implicational 
sentences were presented by ear phone from a cassette tape. The 
authors manipulated both encoding strategies (comprehension or 
memorization instructions) and retrieval procedures (free-recall or 
cued-recall paradigm). DDAVP enhanced recall across encoding and 
retrieval conditions in male subjects, but had no effect on the 
performance of female subjects.
A further study assessing the effects of DDAVP on sentence 
memory employed a cross-over design in which one group of 
subjects received 60 ug DDAVP during a first session and placebo 
during a second session, which occurred approximately seven days 
later (Till & Beckwith, 1985). A second group received similar 
treatment in reverse order, while a third group received placebo 
during both experimental sessions. Each group consisted of 14 
healthy males ranging from 18 to 33 years of age. Following 
treatment, subjects were required to remain in a supine position for 
20 minutes. During the initial session a 16-sentence list was 
presented acoustically at a rate of one new sentence every 20 
seconds. Following a 1 minute distractor task, subjects were given 
5 minutes to complete a free recall. The same procedure was 
followed during the second session; however, subjects were further 
instructed to complete a cued recall for the second session
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sentences, as well as a delayed recall test for the previous session's 
sentence list. Results indicated that DDAVP improved immediate 
recall during Session 1, but not during Session 2. DDAVP was also 
found to facilitate delayed recall for the Placebo-DDAVP group. The 
authors suggested that this finding may indicate a retrieval locus 
for the DDAVP effect. Post hoc analyses of these data further 
suggest that individual differences (e.g. verbal ability) are 
important in understanding the effects of vasopressin on memory. 
DDAVP improved immediate recall more for low-verbal subjects and 
delayed recall more for high-verbal subjects.
Beckwith, Till, Reno and Poland (1990) studied the dose- 
response relationship of DDAVP to sentence memory in healthy young 
adults (age 18-37). Seventy males were divided into five groups 
receiving either 60, 30, 15, 5 or 0 ug of DDAVP. Twenty minutes 
following treatment administration, a list of 16 sentences were 
acoustically presented to the subjects at a rate of one new sentence 
every 20 seconds. After a one minute distractor task, subjects were 
allowed 5 minutes during which to complete a free recall of the 
sentences. Subjects were subsequently presented with a list of 16 
cue words, and given an additional 5 minutes to complete a cued- 
recall. Treatment with 60 ug of DDAVP enhanced cued-recall 
compared to those receiving 5 or 15 ug of DDAVP, but had no effect 
on free recall. Relative to the placebo group, 15 ug of DDAVP 
impaired recall for both free- and cued-recall.
Beckwith, Petros, Bergloff and Staebler (1987) allowed for 
further generalizability to more naturalistic types of learning by 
assessing the effects of DDAVP on recall of narrative prose. Forty 
healthy males (age 18-25) received intranasal treatment with either 
60 ug DDAVP or saline. Twenty minutes following administration, 
six 200-220 word narrative passages were presented at slow, 
medium and fast rates. DDAVP was found to facilitate recall of idea 
units within the passages of both high and medium levels of 
importance. DDAVP had no influence on recall of idea units at the 
low level of importance. The authors interpreted these results as 
evidence that DDAVP "may have facilitated the divided attentional 
processes necessary to integrate text in working memory as 
evidenced by the increased attention to relevant as opposed to 
irrelevant details of the passages presented" (p.431).
To date, only two studies have explored possible differential 
treatment effects on the cognitive performance of male and female 
subjects. Beckwith et al. (1984) first addressed the gender 
question. As previously mentioned, the authors reported enhanced 
sentence recall for males treated with DDAVP, but no treatment 
effect on the performance of female subjects. In view of this 
sexually dimorphic effect and previous literature suggesting 
differential gender-related abilities, Beckwith, Petros and Knutson 
(1990) designed a study to look specifically at the effect of DDAVP 
on performance of both verbal and visuospatial memory tasks in 
male and female subjects. The authors intranasally instilled either
13
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60 ug of DDAVP or saline to 40 male and 40 female subjects (age 
18-30). Approximately 20 minutes following administration, 
subjects participated in Immediate and Final Free Recall of Lists of 
Words, the Paper Folding Test and the Stoop Color Word Test. The 
order of task presentation was counterbalanced across subjects.
The Immediate Free Recall task employed one practice and twelve 
test lists of words.
Although no significant main effects for treatment or gender 
were found, significant three-way interactions suggest that DDAVP 
impaired recall at specific levels of practice, rates of presentation 
and in respect to certain serial positions. Final Free Recall of Lists 
of Words and the Paper Folding Test yielded no main effects or 
significant interactions involving treatment. No main effects or 
interactions involving treatment or gender were found for the word 
and interference subtests of the Stoop Color Word Test; however, 
main effects for treatment and gender, as well as a gender by 
treatment interaction were apparent upon analysis of the color 
naming subtest. DDAVP decreased the mean number of colors named. 
The treatment effect was sexually dimorphic in that DDAVP did not 
effect the performance of males, but impaired the performance of 
females.
Several other studies have focused on the role of vasopressin 
in selective attention. In a study previously discussed, Beckwith et 
al. (1982) used a visual discrimination task to assess the effects of 
vasopressin on the learning of a concept shift problem.
15
Approximately 20 minutes following administration of DDAVP, 
subjects completed a series of visual discriminations. DDAVP 
significantly enhanced learning of all the concept shift problems 
including: original learning, reversal learning, intradimensional shift 
and extradimensional shift. The authors suggested that DDAVP 
enhanced selective attention. In addition, Snel et al. (1987) reported 
that male subjects treated with DGAVP had significantly fewer 
corrected errors on the Bourdon Concentration Test and Beckwith et 
al. (1987) reported facilitation of working memory, again suggesting 
enhanced attention after treatment.
The Sternberg Item Recognition Task, in which the subject is 
asked to decide whether a visually presented digit was a member of 
a previously memorized set of digits, has also been employed to test 
the effects of vasopressin administration on information processing. 
Beckwith, Couk and Till (1983) administered either 60 ug DDAVP in 
0.6 ml solution or the same volume of saline to 15 healthy male 
volunteers (18-24 years of age) according to a cross-over design 
with a 7 day interval between the two sessions. Treatment was 
administered intranasally and preceded the first block of test trials 
by 25 minutes. DDAVP increased alertness, rate of digit encoding 
and rate of response selection when administered during the second 
treatment session. The authors interpret these findings as 
demonstrating improved attentional processing. DDAVP did not 
influence the linear function relating reaction time to memory set
16
size, and is therefore not believed to have had a direct effect on 
memory.
Nebes, Reynolds and Horn (1984) also employed the Sternberg 
paradigm to assess the effects of DDAVP on short-term memory 
processes. In the same study, the authors employed tasks to test 
the neuropeptide's effect on episodic and semantic long-term 
memory, as well as a simple vocal reaction time. Both young and 
elderly males were employed in the study in an attempt to assess 
possible age-related treatment differences. In a cross-over design, 
twenty-four healthy young males (age 20 -30) and twenty-four 
healthy elderly males (age 60-70) received either DDAVP (10 ug on 
Day 1,20 ug on Day 2, 30 ug on Days 3-8) or placebo intranasally for 
2 8-day periods; a 1 month washout period separated the treatment 
periods.
The memory tasks were presented in a counter-balanced order 
at both the beginning and the end of each treatment period. During 
each experimental session, subjects completed 3 series (2 digits, 3 
digits and 4 digits) of 48 trials of the Sternberg task. In an attempt 
to assess DDAVP's effects on episodic memory, subjects were asked 
to memorize a pair of items consisting of two letters (bigram) and a 
one-syllable word beginning with the same two letters. Following 
memorization, subjects were first asked to vocally identify the 
bigrams, and subsequently directed to recall the associated item.
For the semantic memory task, subjects were given 12 semantic 
categories and asked to name a member of that category beginning
with a specified letter. Thirty trials of the simple vocal reaction 
time trials were presented at the beginning and end of each session.
Results of the Sternberg task suggest that DDAVP enhanced 
both retrieval (memory comparison time) and non-retrieval 
(perceptual-motor) stages of short-term memory. Although no 
treatment effect was found for identification, results of the task 
employing episodic long-term memory suggest that DDAVP 
facilitated retrieval of associated items. DDAVP did not affect 
semantic memory access, nor simple vocal reaction time. There was 
no indication of a differential effect on the two age groups. 
Statement of Problem
The results of several of the studies reviewed assessing the 
effects of vasopressin analogs (DDAVP, LVP, TGAVP, DGAVP) on 
various memory paradigms suggest a consistently modest effect of 
vasopressin on human memory. It is difficult to account for the few 
negative findings given the methodologic variance across studies 
(See Table 2). What is impressive is the large number of positive 
findings despite considerable variation in techniques.
In addition to possible differential effects due to 
pharmacological variables, there is evidence that the effect of 
vasopressin on human memory may vary as a function of individual 
differences (e.g. gender, verbal ability). Beckwith et al. (1984;
1990) reported a sexually dimorphic effect. DDAVP was shown to 
enhance sentence recall for male subjects only (Beckwith et al., 
1984), and to impair color naming for female subjects only
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Table 2
Methodological Variables Employed in Studies of the Effects of 





Interval Between Administration and Testing
Time of Day (Administration, Testing)
Gender of Subjects
Method of Testing Memory________________________________________
(Beckwith et al., 1990). In regard to verbal ability, Till & Beckwith 
(1985) found that treatment with DDAVP improved immediate 
sentence memory more for low-verbal subjects, whereas the 
treatment effect for delayed memory was greater for high-verbal 
subjects. Although the relationship between individual differences 
and treatment effects are not entirely clear, these findings suggest 
that variables such as gender and verbal ability may modulate the 
effect of vasopressin on human memory.
The mechanism by which vasopressin affects cognitive 
performance remains to be elucidated. In order to specify the 
cognitive processes modified by the neuropeptide, further research 
must be guided by theoretical models of human memory. There are 
currently two prevailing models: multistore and levels of
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processing models. The multistore model predominated throughout 
the 1960’s (Ashcraft, 1989); however, in the late 1960's and early 
1970's theorists became dissatisfied with the multistore model of 
memory (Craik & Lockhart, 1972). These same theorists argued that 
depth or levels of processing provides a much more comprehensive 
conceptual framework from which research questions may be 
generated.
The multistore models propose three levels of storage: 
sensory stores, short-term memory (STM) and long-term memory 
(LTM) (Atkinson & Schiffrin, 1968). Input to the sensory stores is 
preattentive and a literal representative of the stimuli. However, it 
is not possible to maintain information in the sensory stores, since 
it is overwritten by further inputs of the same modality. Thus, 
while capacity of the sensory stores is large, trace duration is 
transient (1/4-2 seconds). The limited capacity of STM 
(approximately 7 units of information) and the somewhat extended 
rate of forgetting (5-20 seconds) differentiates STM from the 
sensory stores. Entry and maintenance of information within the 
STM require attention and rehearsal, respectively. Verbal input is 
believed to be coded in a phonemic fashion, and information loss 
probably occurs through displacement or decay. There is no known 
limit for LTM capacity or for trace duration. Information loss is 
likely due to loss of accessibility. Rehearsal facilitates entry of 
information into LTM (a large and enduring memory system), and 
maintenance of information occurs through repetition and
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organization. Information is largely semantically coded; however, 
some auditory and visual information may be stored within LTM.
In view of empirical data regarding capacity, coding and 
forgetting characteristics, many theorists have favored the levels 
of processing theory over the multistore models. These theorists 
have argued that perception involves a rapid analysis of stimuli at a 
number of levels or stages, and that memory trace is a result of this 
perceptual analysis (Craik & Lockhart, 1972). According to levels of 
processing theory, preliminary stages of processing encompass 
analysis of physical or sensory features such as lines, angles, 
brightness, pitch and loudness, while deeper stages are more 
concerned with pattern recognition and extraction of meaning. Thus, 
greater "depth of processing" implies a greater degree of semantic 
or cognitive analysis. Deeper levels of analysis are associated with 
more elaborate, longer lasting, and stronger memory traces.
Although it may be "possible to draw a box around the early 
analyses and call it sensory memory and a box around intermediate 
analyses called short-term memory," theorists argue that this 
"procedure both oversimplifies matters and evades the more 
significant issues" (Craik & Lockhart, 1972, p. 675). For example, 
some theorists argue that STM is but a small component of a more 
elaborate working memory (Ashcraft, 1989). While "short-term 
memory" typically refers to the input and storage of new 
information, the term "working memory" is used to depict "the 
mental workplace for retrieval and use of already known
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information" (Ashcraft, 1989, p. 140). Thus, working memory is 
responsible for the retrieval of word meanings and the further 
integration of this information, which results in the understanding 
of a sentence.
Since integration of information in working memory is an 
important factor underlying a subject's ability to remember prose 
material and since vasopressin has been shown to improve recall of 
prose (Beckwith et al., 1987; Posmurova et al., 1983), further 
research is needed to explore the mechanisms through which 
vasopressin may increase the efficiency of working memory. One 
component of prose processing known to influence the efficiency of 
working memory is speed of accessing information from LTM (Haut, 
Beckwith, Petros & Russell, 1989). In the present study, the 
Category Judgement task was employed to obtain measures of 
accessing long-term memory.
Specifically, the current study compared the performance of 
vasopressin-treated subjects with control subjects on the speed and 
accuracy of encoding physical features of a word (word encoding), 
accessing the name of the word (lexical access), and accessing 
categorical information about a word (semantic memory access). 
Subjects were required to make three different types of decisions 
involving a pair of words (physically identical, same name, same 
category). The word pairs were chosen from Rosch's (1975) 
semantic category list. Rosch has previously shown that accessing 
categorical information requires more processing time than
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accessing information about the name of a word, or encoding the 
letters or physical features of a word. Thus, if vasopressin affects 
access speed, the effect should increase as the decisions 
necessitate more processing time (i.e., categorical information).
Secondly, as indicated above, individual differences may 
influence the nature of the effect found after treatment with 
vasopressin; therefore the present study was designed to examine 
possible gender differences in the effects of vasopressin on the 
speed of accessing long-term memory. Gender differences are quite 
probable in view of animal studies which report a sexually 
dimorphic effect of AVP on retention of a passive-avoidance 
response (Tinius et al., 1987; Swenson et al., 1990) and human 
studies reporting a sexually dimorphic effect on human cognition 
(Beckwith et al., 1985; 1990). The sexually dimorphic effect of this 
neuropeptide may well be the result of differential distribution of 
vasopressinergic neurons in the developing brain. Swaab and Boer 
(1983) point out that at day 12 of life male rats have a denser 
vasopressinergic innervation of the lateral septum and lateral 
habenula than female rats. In addition, Buijs (1987) has noted a 
differential distribution of vasopressin in the CNS of adult male and 
female rats. Therefore, the present study assessed performance of 




Forty-one female and forty-three male undergraduate college 
students ranging from 18 to 34 years of age participated in the 
current study. A self-report questionnaire was employed to screen 
subjects for health-related problems. Individuals with a history of 
cardiovascular problems and/or hypertension, as well as females 
using oral contraceptives, were excluded from participation in the 
study. Each female subject was tested during the first five days of 
her menstrual cycle to minimize the possibility of pregnancy and to 
insure that endogenous hormonal effects remained relatively 
constant among female subjects. During the 48 hour period prior to 
participation in the study, all subjects were free of alcohol and 
caffeine, as well as over-the-counter and prescription medications. 
The procedures used in the study were reviewed and approved by the 
University Institutional Review Board and subjects were informed of 
their right to withdraw from participation at any time during the 
study.
M ateria ls
Screening Questionnaire. A screening questionnaire (See 
Appendix A) was constructed to elicit self-report of variables which
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might confound treatment effects. Subjects were asked to report 
the frequency and amount of all drug usage. Subjects were asked 
specifically about their use of caffeine, alcohol and nicotine. In 
addition, the subjects were asked to describe their general health in 
the last year, as well as specific medical conditions (i.e. high blood 
pressure, allergies, ulcers, cardiovascular disease and epilepsy). If 
the individual subject acknowledged the use of prescription or over- 
the-counter medication, he/she was asked to describe the reason for 
taking the medication and the duration of usage. Females were 
further questioned regarding pregnancy and the use of oral 
contraceptives. Lastly, subjects were asked if they would be 
willing to participate in a study of the effects of vasopressin on 
memory.
Blood Pressure. A Marshall 85 oscillometric 
sphygmomanometer (manufactured by Omron Marshall Products, Inc., 
Lincolnshire, Illinois) was used to obtain measures of systolic and 
diastolic blood pressure. The electronic device presented digital 
information, which was observed and manually recorded.
Vocabulary Test. The vocabulary subtest from the Wechsler 
Adult Intelligence Scale - Revised (WAIS-R; Wechsler, 1981) was 
used to obtain an objective assessment of each subject's word 
knowledge. The WAIS-R vocabulary test consists of 35 words, which 
are verbally administered in an order of increasing difficulty. 
Responses were scored zero, one or two points according to the 
scoring criteria found in Appendix A of the WAIS-R manual. Raw
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scores on the WAIS-R vocabulary subtest range from 0 to 70. The 
vocabulary test together with Information and Block Design are the 
most reliable of the WAIS-R subtests across all age groups, and have 
the smallest standard error measurements. For individuals from 18- 
35 years of age, reliability on the vocabulary subtest ranges from 
.94-.96, and the standard error of measurement ranges from .52-.67.
Treatm ent. Desmopressin acetate (DDAVP), a synthetic analog 
of 8-arginine vasopressin, is manufactured by Rorer Pharmaceutical 
Corporation, Fort Washington, Pennsylvania. The primary structure 
of the analogue is as follows: C48H74N14O 17S2 [SCH2CH2CO-Tyr- 
Phe-GIn-Asn-Cys] -Pro-D-Arg-Gly-NH2 .C2H4O2.3H2O. The active 
structure is 1 (3-mercaptopropionic acid)-8-D-arginine vasopressin. 
The intranasal preparation of DDAVP is a sterile, aqueous solution. 
Each ml of solution contains 0.1 mg Desmopressin acetate, 5.0 mg 
Chlorobutanol, 9.0 mg Sodium chloride and Hydrochloric acid to 
adjust pH to approximately 4. The intranasal preparation of DDAVP 
has antidiuretic activity of about 400 IU (Physician's Desk 
Reference, 1989). Compared to arginine vasopressin, DDAVP has 
reduced vasopressor and antidiuretic effects.
Category Judgement. In the present study, the Category 
Judgement task was employed. In this particular task the subject is 
confronted with a word pair, and asked to make a decision regarding 
the similarity or the disparity of the two words. The word pairs 
were chosen from Rosch's (1975) semantic category list and are all 
highly typical, possessing a rank of 30 or less on Rosch's normative
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scale (See Appendix B for word lists). The Category Judgement task 
employs three types of decisions: physically identical (PI), for 
example, DOG/DOG; same name (SN), for example, DOG/dog; and same 
category (SC), for example, DOG/cat. The categories employed were 
furniture, vehicles, birds, clothes, tools, sports, weapons and fruits. 
The eight categories occurred equally often for each decision type. 
The subjects were required to judge the two words as "the same" or 
"different." Upper and lower cases appeared equally often for both 
positive and negative decisions. The word pairs were presented by 
an Apple lie computer and were displayed on a monochrome screen. 
The words were presented in sequences of 96 word pairs such that 
32 word pairs were used for Physical Identity (PI) decisions, 32 
word pairs were used for Same Name (SN) decisions and 32 word 
pairs were used for Same Category (SC) decisions. One half of the 
decisions were positive and one half were negative; thus, sequences 
containing 96 trials were composed of 16 trials per condition.
Reaction Time Control. The reaction time control task was 
employed in the current study to assess the time required to 
complete the motor task of pressing a computer key. The task 
begins with the appearance of the word "right" or "left" on the 
computer screen. The words instructed the subject with which 
index finger to respond. The stimulus word was presented on the 
computer screen and remained for three seconds. Since memory 
access was assumed complete following this delay, the subsequent 
response time was considered an index of the time needed to execute
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the motor component of the response. This measure aided in 
distinguishing the effect on memory produced by exposure to DDAVP 
from possible effects on the time required for the motor response. 
Procedure
Subjects, who reported an absence of chronic and acute 
illnesses and who denied use of medication, alcohol and other drugs 
during the 48 hours prior to experimentation, were briefed regarding 
the nature of the hormone to be administered, possible side-effects 
and the tasks involved in participation. Subjects were further 
screened for high blood pressure. At the beginning of the 
experiment, all subjects had blood pressures less than 140/90 mm 
of Hg. Upon completion of the screening procedures, subjects were 
asked to sign an informed consent form (Appendix C), and notified of 
their right to withdraw from the study at any time. After informed 
consent was obtained, the vocabulary test was administered. To 
insure that both groups were equivalent in terms of their verbal 
ability, subjects were assigned to either the DDAVP or placebo 
treatment condition based on the subject's raw vocabulary in a 
manner ensuring similar verbal ability between groups.
Instillation of Hormone and Placebo. Following group 
assignment, the subjects were instructed to recline in a supine 
position with the head tilted backwards. While the subject reclined, 
an intranasal preparation of 60 ug DDAVP in 0.6 ml of solution or 0.6 
ml of saline was slowly instilled over approximately a 15 second 
interval. The solution was instilled into one nostril (usually the
right). To insure absorption by the intranasal mucous membranes, 
subjects were instructed to remain in the supine position for 20 
minutes following administration.
T esting. Following the absorption period, all subjects received 
a sequence of practice trials (twelve trials per condition) followed 
by 16 experimental trials per condition (96 experimental trials 
total). Response time, the time between stimulus onset and motor 
response, and the accuracy of the response were recorded and stored 
for analysis. Upon completion of the experimental trials, the 
subjects completed a sequence of 32 reaction time control trials.
Unexpected Free Recall. After completing the reaction time 
control trials, subjects were asked to recall as many of the words 
as possible. It is important to note that the subjects were not 
previously briefed regarding the free recall; thus, the data obtained 
from the unexpected free recall served as an index for incidental 
learning. Upon completion of the free recall task, the subjects were 
debriefed and allowed to depart. All testing was completed between 




All data analyses were conducted with alpha set at .05. The 
Newman-Keuls procedure was used for further analysis of main 
effects and interactions.
Individual Differences
Age of the subjects, raw score on the WAIS-R vocabulary 
subtest, systolic and diastolic blood pressure and self-reported 
weight were analyzed by means of a 2 (group) by 2 (gender) between 
groups analysis of variance (ANOVA) to determine if the groups 
(DDAVP females, DDAVP males, placebo females, placebo males) 
differed on any of these individual variables prior to treatment. A 
one-way between groups ANOVA was conducted on the day of the 
menstrual cycle on which the female subjects participated. The 
ANOVA tables are presented in Appendix D (See Tables 11-16).
The analysis on age of the subjects revealed no main effects of 
group, F(1,80)<1, p>.50, or gender, F(1,80)=2.57, p=.11. The group by 
gender interaction was not significant, F(1,80)=1.55, p=.22. For the 
WAIS-R vocabulary subtest raw score, there were no main effects of 
group, F(1,79)<1, p>.50, or gender, F(1,79)=1.64, p=.21. The group by 
gender interaction, F(1,79)<1, p>.50, was not significant. One male's 
data (DDAVP group) was excluded from the analysis, because of
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familiarity with the subtest. The means and standard deviations are 
presented in Table 3.
Table 3
Mean Age and Mean WAIS-R Vocabulary Subtest Raw Score for 
Female and Male Subjects at Each Level of Treatment
30
Age WAIS-R vocabulary subtest 
raw score
Female Male Female Male
DDAVP
M 19.10 21.00 47.50 49.76
m 1.80 3.38 6.95 6.99
Placebo
M 20.14 20.38 46.29 48.62
m 3.99 2.52 9.21 9.17
For diastolic blood pressure, there were no main effects of
group, F(1 ,79)<1, p=.48, or gender, F(1,79)=2.20, p=.14. The group by 
gender interaction was not significant, F(1,79)<1, p>.50. For the 
systolic blood pressure, the results revealed a main effect of gender 
(F(1,79)=32.13, p<.001) in that male subjects had higher systolic 
blood pressure than female subjects. The main effect of group,
F(1,79)<1, p>.50, and the group by gender interaction, F(1,79)<1, 
p>.50, were not significant. Analysis of covariance adjusting for 
systolic blood pressure did not affect the results of the analyses of
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variance on the dependent variables for subsequent analyses. The 
means and standard deviations are presented in Table 4.
Table 4
Mean Diastolic and Mean Systolic Blood Pressure for Female and Male 
Subjects at Each Level of Treatment
Diastolic Blood Pressure Systolic Blood Pressure
Female Male Female Male
DDAVP
M 66.80 68.95 110.15 121.62
3D 8.59 5.44 10.04 9.48
Placebo
M 65.24 68.14 111.00 123.10
3D 10.28 5.76 9.45 8.90
Males in this study's sample weighed significantly more than 
females, F(1,78)=55.23, p<.001. The analysis on weight revealed 
neither significant effects for group, F(1,78)<1, p>.5, nor a group by 
gender interaction, F(1,78)=1.24, p=.27. Analysis of covariance 
adjusting for weight did not affect the results of the analyses of 
variance on the dependent variables for subsequent analyses. The 
day of the menstrual cycle on which female subjects participated in 
the study was not significantly different between groups,
F(1,39)=1.14, p=.30. The means and standard deviations are 
presented in Table 5.
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Table 5
Mean Self-reported Weight for Female and Male Subjects and Mean 
Dav of Menstrual Cycle for Females at Each Level of Treatment
Weight__________  Day of Menstrual Cycle
Female Male Female
DDAVP
M 138.00 168.50 3.90
3Q 20.30 24.30 1.37
Placebo
M 134.05 175.30 3.48
3Q 17.89 23.99 1.17
Response Times
The median response time was obtained for every subject in 
each cell of the design. Response times associated with errors were 
excluded. The F max test with alpha set at .05 revealed 
heterogeneity of variance for the raw data. A logarithmic 
transformation (log 10) was performed on the data to reduce 
heterogeneity of the variance. The transformed data were analyzed 
by means of a 2 (treatment) x 2 (gender) x 3 (decision type) x 2 
(response type) mixed analysis of variance with repeated measures 
on the last two factors. The ANOVA table is presented in Appendix D 
(See Table 17).
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The analysis of median response times on the experimental 
trials yielded no significant main effects of treatment, F(1,80)<1, 
p>.50, or gender, F(1,80)<1, p>.50. Main effects were found for 
decision type, F(2,160)=870.80, p<.001, and for response type,
F(1,80)=75.97, p<.001. Subjects required significantly more time to 
respond to semantic (same category) decisions than to lexical (same 
name) decisions, which required significantly more time to respond 
than decisions based on physical features (physically identical). 
Subjects responded more quickly to positive decisions than to 
negative decisions.
A significant interaction of decision type by response type 
was observed, F(2,160)=17.24, p<.001. Subsequent Newman-Keuls 
testing revealed that subjects responded significantly slower on 
negative decision trials than positive trials for all decisions; 
however, the size of the difference between positive and negative 
response times (same/different effect) varied as a function of 
decision type. For example, same/different effects were 2.69%, 
4.64% and 11.58% for PI, SN and SC decisions, respectively (Percent 
differences were calculated by dividing the absolute difference by 
the larger number). No other 2 or 3 way interactions were 
significant. Means and standard deviations are presented in Table 6. 
Response Time Control
Median response time for response time controls were 
obtained for each subject. The F max statistic was used to test for 
homogeneity of the variance with alpha set at .05. Because the
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Table 6
Median Response Time on Positive and Negative Experimental Trials 
for Subjects at Each Level of Treatment and Decision Type
Positive Negative
PI SN SC PI SN SC
DDAVP
M 640.12 658.83 1094.19 635.15 694.21 1239.67
£D 126.15 78.04 196.20 98.14 85.10 212.98
Placebo
M 638.54 680.48 1070.46 679.48 710.24 1208.01
£Q 179.89 213.21 351.46 249.55 183.26 308.87
assumption of homogeneity was violated, the data were transformed 
using a logarithmic transformation (Iog10). A 2 (treatment) x 2 
(gender) x 2 (response handedness) mixed analysis of variance was 
conducted on the transformed data. The ANOVA table is presented in 
Appendix D (See Table 18).
Analysis of the transformed response time control data 
revealed no significant main effects of treatment, F(1,80)=2.41, 
p=.13, or gender, F(1,80)=2.80, p=.10. A main effect of response 
handedness, F(1,80)=9.86, p=.003, was found, as was a significant 
treatment by response handedness interaction, F(1,80)=6.73, p=0.01 
(See Figure 1). Subjects treated with DDAVP responded significantly 
slower with both hands, and slower with the right hand compared to
35
Response Handedness
Figure 1. Median response time controls as a function 
of treatment and response handedness.
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left handed responses. Subjects treated with the placebo did not 
differ in regard to response handedness. No other 2 or 3 way 
interactions were significant. Means and standard deviations are 
presented in Table 7.
Table 7
Median Response Time Controls for Subjects at Each Level of 









A 2 (treatment) x 2 (gender) x 3 (decision type) x 2 (response 
type) mixed analysis of variance was performed on data generated by 
subtracting RTC trials from the overall response times (median
i
experimental data minus median response time control data from the 
corresponding cell of the design). Since the assumption of 
homogeneity of the variance was violated for both the overall 
response time data and the response time control data, a logarithmic 
(log 10) transformation was performed on the difference scores prior
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to the ANOVA. The ANOVA table is presented in Appendix D (See 
Table 19).
The pattern of the main effects found in this analysis was 
similar to that found in the analysis of response times. Results of 
the analysis indicated significant main effects for decision, 
F(2,160)=821.52, pc.001, and response, F(1,80)=73.91, pc.001. 
Subjects required significantly more time to respond to semantic 
(same category) decisions than to lexical (same name) decisions, 
which required significantly more time to respond than decisions 
based on physical features (physically identical). Subjects 
responded more quickly to positive decisions than to negative 
decisions. Main effects of treatment, F(1,80)c.001, p>.50, and 
gender, F(1,80)=1.26, p=.27 were not significant.
The treatment by decision interaction, which was not 
significant in the analysis of response times, was found to be 
significant in the analysis of difference scores, F(2,160)=3.20, p=.04 
(See Figure 2). Subjects treated with DDAVP responded more quickly 
to physically identical decisions than subjects receiving placebo.
The treatment effect was not apparent for the other two types of 
decisions. Similar to results of the analysis conducted on the 
response times, the decision by response interaction was found to be 
significant, F(2,160)=8.76, p<.001. Subjects responded significantly 
slower on negative decision trials than positive trials at all levels 

















Figure 2. Median difference scores as a function 
of treatment and decision type.
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a function of decision type. For example, same/different effects 
were 1%, 1.69% and 2.58% for PI, SN and SC decisions, respectively. 
Error Rates
Proportion of errors made during the experimental trials were 
computed for every subject at each cell of the design. The F max 
test with alpha set at .05 indicated heterogeneity of the variance; 
thus the proportions were transformed using the Arc sine 
transformation. A 2 (treatment) x 2 (gender) x 3 (decision type) x 2 
(response type) analysis of variance was conducted on the 
transformed proportion of errors. The ANOVA table is presented in 
Appendix D (See Table 20). Means and standard deviations are 
presented in Tables 8 and 9.
The analysis revealed a significant main effect for decision 
(F(2,160)=68.58, p<.001) in that subjects made a higher proportion 
of errors on same category decisions than on same name or 
physically identical decisions. Proportion of errors was also higher 
for same name decisions compared to proportion of errors on 
physically identical decisions. Main effects of treatment, F(1,80)<1, 
p>.50, gender, F(1,80)< 1, p>.50, and response, F(1,80)<1, p>.50, were 
not significant.
A significant treatment x gender interaction was found,
F(1,80)=5.63, p=.02 (See Figure 3). Newman-Keuls conducted on the 
differences between the simple effects means did not reveal any 
significant pairwise comparisons; however, the observed 
differences (.049 for females and .046 for males) approached
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Table 8
Proportion Errors from Positive Experimental Trials for Female and 
Male Subjects at Each Level of Treatment and Decision Type
Female Male
PI SN SC PI SN SC
DDAVP
M 0.022 0.047 0.116 0.051 0.071 0.145
3Q 0.047 0.053 0.080 0.046 0.065 0.103
Placebo
M 0.024 0.045 0.167 0.018 0.048 0.086
m 0.046 0.053 0.122 0.029 0.056 0.078
Table 9
Proportion Errors from Negative Experimental Trials for Female and 
Male Subjects at Each Level of Treatment and Decision Type
Female Male
PI SN SC PI SN SC
DDAVP
M 0.038 0.028 0.100 0.063 0.060 0.085
3Q 0.068 0.038 0.077 0.070 0.065 0.097
Placebo
M 0.045 0.065 0.158 0.054 0.036 0.110
3Q 0.056 0.070 0.098 0.060 0.047 0.081
significance (critical F equals .056). The treatment effect appeared 
to vary as a function of gender. For example, DDAVP-treated 
females had 29.76% fewer errors than placebo-treated females, and 
DDAVP-treated males had 25.32% more errors than placebo-treated 
males. A significant treatment by response interaction,
F(1,80)=7.17, p=.01 (See Figure 4), was also found. Subjects treated 
with placebo had a significantly higher error rate on negative 
responses; however, subjects treated with DDAVP did not differ 
significantly in regard to response type.
Significant interactions for gender by decision, F(2,160)=6.51, 
p=.002, and decision by response, F(2,160)=3.72, p=.03, were also 
indicated. Males made more errors on the physically identical 
decisions, whereas females had a higher rate of errors on same 
category decisions. The gender difference on same name decisions 
was not significant. The decision by response interaction resulted 
from a higher rate of errors on negative trials compared to positive 
trials for physically identical decisions. Error rates on positive and 
negative response types did not differ for the same name or same 
category decisions. No other 2 or 3 way interaction were 
s ig n ifican t.
Unexpected Free Recall
The proportion of words recalled from each subject's free 
recall was computed. The F max test with alpha set at .05 revealed 
heterogeneity of variance for the raw data; thus, the Arc sine 








































Yes _  _  NoResponse Type
Figure 4. Proportion of errors as a function of 
treatment and decision type.
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reduce heterogeneity of the variance. The transformed data were 
analyzed by means of a 2 (treatment) x 2 (gender) x 3 (decision type) 
x 2 (response type) analysis of variance with repeated measures on 
the last two factors. The ANOVA tables are presented in Appendix D 
(See Table 21). Means and standard deviations are presented in 
Table 10.
Table 10
Proportion Recall from Positive and Negative Experimental Trials 
for Subjects at Each Level of Treatment and Decision Type
Positive Negative
PI SN SC PI SN SC
DDAVP
M 0.152 0.135 0.197 0.086 0.065 0.118
3Q 0.086 0.076 0.083 0.055 0.052 0.072
Placebo
M 0.262 0.268 0.303 0.145 0.129 0.183
m 0.941 0.938 0.457 0.469 0.470 0.466
The analysis of variance on proportion recall yielded no 
significant main effects of treatment, F(1,79)=1.16, p=.29, or 
gender, F(1,79)< 1, p>.50. A main effect was found for decision, F(2, 
158)=39.91, p<.001. Post-hoc testing revealed a significantly higher 
proportion of words recalled from the same category decision task 
than from the physically identical and the same name decision tasks.
4 4
A significant main effect for response type was found 
(F(1,79)=100.61, p<.001) in that subjects recalled a higher 
proportion of words from positive decision trials than from negative 
decision trials.
A significant decision type by response type interaction was 
also revealed, F(2,158)=3.21, p=.04. Subjects recalled a higher 
proportion of words from positive decision trials than from negative 
decision trials at all levels of decision, and subjects' recall was 
higher from same category trials compared to recall from same 
name or physically identical decision trials. For negative decision 
trials only, recall from physically identical decision trials was 
significantly higher than recall from same name decision trials. No 




Speed of accessing long-term memory was not affected by 
treatment with DDAVP. These results do not support the hypothesis 
that DDAVP improves the efficiency of working memory through 
speed of accessing long-term memory. There are several possible 
explanations for the lack of a treatment effect. First, the task may 
not be a valid estimate of accessing time; however, this conclusion 
does not seem likely as discussed below. Secondly, raw response 
time may measure more than the time necessary to access long­
term memory (e.g. stimulus identification, response selection and 
response programming, as well as the motor component of the task); 
thus, the drug effect on long-term memory access may not be 
apparent. This perspective is discussed further in regard to analysis 
of the difference scores. Thirdly, the lack of a treatment effect may 
mean that there is no effect of DDAVP on speed of accessing long­
term memory. In which case, other components of working memory 
may be responsible for the proposed increase in the efficiency of 
working memory, which is theorized to be responsible for enhanced 
recall of prose material.
4 5
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Speed of accessing long-term memory as measured by response 
times did not differ in regard to gender. The lack of a gender effect 
is consistent with findings presented by Haut et al. (1989). In a 
study assessing the effect of acute intoxication with ethanol on 
speed of accessing long-term memory, no gender differences were 
found for sober subjects. Thus, speed of accessing long-term 
memory does not appear to differ simply as a function of gender.
Task effects including main effects for decision type and 
response type were found, as was a decision type by response type 
interaction. These task effects are consistent with levels of 
processing theory, as well as previous studies employing similar 
tasks. That is, deeper levels of processing require longer processing 
time (Craik and Lockhart, 1972). In the current study, semantic 
(same category) decisions required more processing time than 
lexical (same name) decisions, which required more processing time 
than decisions based on physical features (physically identical).
This main effect for decision type has consistently been shown in 
previous studies (Rosch, 1975; Craik & Tulving, 1975; Chabot, Miller 
& Juola, 1976; Goldberg, Schwartz & Stewart, 1977; Petros, Zehr & 
Chabot, 1983; Haut et al., 1989).
Subjects responded more quickly to positive decisions than to 
negative decisions. This is also a standard task effect previously 
reported in the literature (Chabot et al., 1976; Petros et al., 1983; 
Haut et al., 1989). The finding that response times are shorter for 
same judgements than for different decisions has been termed the
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"same/different effect" (Noordman-Vonk, 1979). Theorists have 
proposed a model to account for the same/different effect. The 
model suggests that subjects first try to find positive evidence 
with respect to the criterion in the task. If no positive evidence is 
found, a search for differences between the concepts is conducted. 
The decision type by response type interaction found in the present 
study, in which the same/different effect varied as a function of 
decision type, was also reported by Haut et al. (1989).
The consistency between results of previous literature using 
similar tasks and the present findings, as well as the congruence 
between these results and levels of processing theory suggest that 
the task is a valid measure of the speed of accessing long-term 
memory. The possibility remains that raw response time may 
include a multitude of processes which conceal a drug effect on 
accessing time. In an attempt to subtract the motor component of 
the task, as well as other cognitive components (e.g. stimulus 
identification, response selection and response programming) from 
the response time measures, a response time control task was 
implemented and later subtracted from the raw response times. 
Response Time Control
The response time control (RTC) task was employed to assess 
the time required to complete the motor task of pressing a computer 
key, and thus aid in distinguishing the effect on memory produced by 
exposure to DDAVP from possible effects on the time required for 
the motor response. Analysis of the RTC data suggests that DDAVP
slowed reaction time for both the right and left hands, and that right 
handed responses were slower than left handed responses for 
DDAVP-treated subjects. Response time did not differ in regard to 
response handedness for subjects treated with the placebo.
Results of previous studies assessing the effect of DDAVP on 
reaction time are inconclusive. Millar et al. (1987) administered 40 
ug of DDAVP to healthy young male subjects, and found no effect for 
a simple, unprepared visual reaction time task. The fact that 60 ug 
of DDAVP was found to retard reaction time in the present study is 
inconsistent with the nonsignificant findings of Millar et al.; 
however, the results may not be directly comparable, since the two 
studies used different doses of DDAVP, as well as a somewhat 
different task.
Another study which assessed the effects of chronic 
administration of 30 ug of DDAVP on numerous memory tasks, 
further investigated the effects of the neuropeptide on simple vocal 
reaction time and found no effect (Nebes et al., 1984). However, this 
reaction time task differed significantly from the present task in 
that it measured vocal latency from the onset of a stimulus, 
whereas the task employed in the present study measured motor 
response time from the offset of a stimulus. Furthermore, Nebes et 
al. employed chronic administration of a smaller dose of DDAVP, 




Results of the present study are also inconsistent with results 
of a recently published study assessing the effects of DDAVP on 
movement planning and execution processes in healthy young adults 
(Carter, Williams, Davis, Rotter & Clancy, 1991). Carter et al. 
reported that an acute dose of 60 ug of DDAVP decreased reaction 
time on both a simple reaction time task and a complex movement 
task. The effect of DDAVP on the simple reaction time task utilized 
by Carter et al. is most similar to the task employed in the current 
study. During this task, subjects were reportedly seated facing a 
motor sequencing apparatus with a warning/stimulus light placed on 
the top center. The subjects were instructed to depress the 
telegraph key with the index and third fingers of their dominant 
hand. A randomized forewarning period (1, 2 or 3 seconds in 
duration) was signaled by a white light, following which a red 
stimulus light appeared. In response to the stimulus light, subjects 
were instructed to respond by lifting the fingers as quickly as 
possible. DDAVP-treated subjects responded faster than subjects 
receiving the placebo.
Discrepant results between the study published by Carter et al. 
(1991) and the present study may be explained by the fact that 
subjects in the previous study responded with only the dominant 
hand, whereas subjects in the current study responded equally with 
the right and left hands. Additionally, the responses differed in that 
subjects in the current study were instructed to respond at the 
cessation of a stimulus, while Carter et al. instructed subjects to
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respond at stimulus onset. It is also possible that the RTC task 
employed in the present study may not have been a true simple 
reaction time task. Reaction time is defined as the time from the 
appearance of a sudden and unanticipated signal to the beginning of a 
volitional motor response. Thus, reaction time encompasses the 
time required by the central nervous system for stimulus 
identification, response selection and response programming 
(Schmidt, 1985). By definition, response selection and programming 
are minimal in a simple reaction time task. The task used by Carter 
et al. (1990) attempted to minimize response selection and 
programming, whereas the RTC task utilized in the present study 
incorporated a three second forced delay during which response 
selection and programming were theorized to be complete. However, 
the discrepant results between the current study and the study 
reported by Carter et al. suggest that the task employed in the 
current study may have measured some of the cognitive processes 
which underlie response time, as well as the motor component of the 
task.
Difference Scores
Despite the uncertainty regarding the response time control 
data, difference scores were computed by subtracting RTC trials 
from the overall response times (median experimental data minus 
median response time control data from the corresponding cell of 
the design). If the RTC task does in fact capture the motor 
component of response time plus the time necessary for completion
51
of the cognitive processes involved in response selection and 
programming, then the difference scores should represent the time 
necessary to complete the remaining cognitive processes associated 
with each decision type (PI, SN, SC).
Similar to the results of the analysis of response times, 
analysis of the difference scores yielded no significant main effect 
for treatment with DDAVP, and response times did not differ in 
regard to gender. Task effects including main effects for decision 
type and response type were found, as was a decision type by 
response type interaction. As discussed above these are standard 
task effects, which have been reported by numerous authors (Rosch, 
1975; Craik & Tulving, 1975; Chabot et al., 1976; Goldberg et al. , 
1977; Petros et al., 1983; Haut et al., 1989).
Unique to the analysis of difference scores, was a significant 
treatment by decision interaction, such that DDAVP-treated 
subjects responded more quickly to physically identical decisions. 
The treatment effect was not apparent for decisions requiring either 
lexical access or category decisions. Goldberg et al. (1977) have 
speculated that physically identical decisions may require access to 
a different memory store than either homophone identity matching 
or taxonomic category identity matching. That is, physically 
identical decisions may require retrieval of information only from 
short-term memory. If this is in fact the case, then DDAVP may 
facilitate processing within short-term memory. This speculation 
is consistent with Pietrowsky et al.'s (1988) report that DGAVP
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enhanced the recency effect, since the recency effect is classically 
seen as a measure of information maintenance within short-term 
memory (Ashcraft, 1989). Results suggesting that DDAVP 
facilitates short-term recall, while impairing long-term memory 
also appear consistent with the speculation that the present results 
indicate a facilitative effect specific to short-term memory (K. 
Millar, personal communication, March 25, 1988).
An alternative explanation suggests that physically identical 
decisions may actually require at least some access to 
lexicographically coded information stored in long-term memory 
(Goldberg et al., 1977). If this is true, theorists suggest that the 
data base involved is likely much less complex than the organization 
of the data bases containing phonemic and taxonomic information. 
Thus, DDAVP may facilitate retrieval of information from a less 
complicated organizational scheme within long-term memory. At 
this time no definite conclusion regarding whether the particular 
memory store involved in physically identical decisions is short­
term or long-term memory can be rendered.
The fact that DDAVP was not found to facilitate access to 
semantic memory in the current study appears consistent with 
findings published by Millar et al. (1987) and Nebes et al. (1984). 
Millar et al.(1987) treated subjects with 40 ug of DDAVP and 
reported a nonsignificant treatment effect on decision latencies 
associated with semantic recognition. After 8 days of intranasal
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DDAVP treatment, Nebes et al. (1984) found that treatment had no 
effect on semantic memory access.
Error Rates
Error rates are a difficult measure to interpret, and are 
typically seen as a secondary dependent variable. Rosch (1975) 
suggested that reaction time appears to be the appropriate variable 
for analysis, since subjects are encouraged to emphasize 
correctness in responses and since the practice trials tend to reduce 
the overall proportion of errors. Overall average error rates 
reported in previous studies range from 4% to 10.7% (Beller, 1971; 
Rosch, 1975; Chabot et al., 1976; Goldberg et al., 1977; Petros et al., 
1983). The average overall error rate found in the current study was 
7%. The correlation between response times and error rates, 
r(502)=.29, suggest that speed accuracy tradeoffs were not a 
problem in the data.
Although analysis of the proportion of errors did not yield a 
significant main effect for treatment or gender, significant 
treatment by response and treatment by gender interactions were 
found. Subjects treated with placebo had a significantly higher 
proportion of errors for negative decisions compared to positive 
decisions. Treatment with DDAVP appeared to eliminate the 
same/different effect for error rates.
The treatment by gender interaction indicated that females 
treated with DDAVP had a lower proportion of errors than placebo- 
treated females, whereas DDAVP-treated males had a higher
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proportion of errors than males in the placebo-group. This result 
suggests that there may be a sexually dimorphic effect of the 
vasopressin analog. Differential treatment effects in regard to 
gender have been previously published. Beckwith et al. (1984) 
demonstrated enhanced sentence recall for males only, while 
Beckwith et al. (1990) found that acute treatment with DDAVP 
impaired color naming for female subjects only. Documented 
differential distributions of vasopressinergic neurons found in the 
developing rat brain (Swaab and Boer, 1983), as well as the CNS of 
adult male and female rats (Buijs, 1987), suggest that neurological 
differences may underlie gender-related performance differences in 
both nonhuman and human animals. The gender differences in 
response to treatment with DDAVP appear to be quite small and 
subtle.
Significant task effects found in the analysis of the error 
rates include a main effect for decision type and a decision type by 
response type interaction. Subjects made more errors on same 
category decisions than on same name decisions or physically 
identical decisions. This finding is consistent with the results 
reported by Chabot et al., 1976. Additionally, in the current study 
the proportion of errors on same name decisions was higher than the 
error rate for physically identical decisions. Haut et al. (1989) 
found the same pattern of results for positive decisions, but did not 
find a significant main effect of decision type for the negative 
trials. The significant decision type by response type interaction
found in the current study indicated that subjects made more errors 
on negative trials compared to positive trials for physically 
identical decisions. Error rates on positive and negative decisions 
did not differ for the same name or same category decisions.
In addition to the task effects, the analysis of error rates 
revealed a significant gender by decision type interaction such that 
males had a significantly higher proportion of errors on physically 
identical decisions, while females had significantly more errors on 
same category decisions. This finding is inconsistent with the 
results reported by Goldberg et al. (1977), which showed no gender 
differences in error rates for physically identical decisions. The 
authors did report a significant gender effect for homophone 
identity matching errors; males made significantly more errors at 
this level of decision.
Incidental Learning
Treatment with DDAVP did not affect proportion of recall.
Since the recall was unexpected, the data suggest that this analog of 
vasopressin does not affect incidental learning from this orienting 
task. Results of previous studies utilizing the free recall paradigm 
and lists of words are inconclusive. Both Fehm-Wolfsdorf et al. 
(1984) and Beckwith et al. (1984) reported a nonsignificant 
treatment effect within the free recall paradigm. However, both 
Fehm-Wolfsdorf et al. (1983) and Pietrowsky et al. (1988) have 
shown that vasopressinergic analogs affect free recall of lists of 
words. Fehm-Wolfsdorf et al. (1983) reported a prolonged primacy
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effect following treatment with LVP, and Pietrowsky et al. (1988) 
found that DGAVP attenuated the primacy effect and enhanced the 
recency effect.
While the current nonsignificant treatment effect is 
consistent with the results published by Fehm-Wolfsdorf et al. 
(1984) and Beckwith et al. (1984), the finding is inconsistent with 
the latter two studies. These results may not be directly 
comparable, however, since the current study employed incidental 
learning and the studies utilizing recall of lists of words examined 
intentional learning. Craik and Lockhart (1972, p. 677) suggest that 
"under incidental learning conditions, the experimenter has a control 
over the processing the subject applies to the material that he does 
not have when the subject is merely instructed to learn and uses an 
unknown coding strategy." Thus, DDAVP does not appear to affect 
memorial consequences specific to this orienting task, but may 
affect one or more other encoding strategies employed under 
intentional learning conditions.
Subjects' recall was not found to differ in regard to gender. 
Significant main effects for decision type and response type were 
found, as was a significant decision type by response type 
interaction. The task effects found in the current study are 
consistent with previous literature. A higher proportion of recall 
from same category decisions compared to recall from same name 
and physically identical decisions was found in the current study and 
has been reported by numerous authors (Rosch, 1975; Craik &
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Tulving, 1975; Chabot et al., 1976; Goldberg et alM 1977). The main 
effect for decision type found in the analysis of the recall data is 
also consistent with levels of processing theory, which postulates 
that the durability of the memory trace is a function of depth of 
processing (Craik & Lockhart, 1972). Stimuli which are fully 
analyzed and enriched by associations or images result in a deeper 
encoding process, and a long-lasting memory trace, whereas stimuli 
which do not receive full attention, and are analyzed only at a 
shallow sensory level, produce transient memory traces.
The higher proportion recalled from positive decisions 
compared to the proportion recalled from negative decisions is also 
consistent with previous findings (Schulman, 1974; Craik & Tulving, 
1975; Chabot et al., 1976). Craik and Tulving (1975) have suggested 
that the higher recall for positive decisions reflects a higher degree 
of encoding elaboration. For example, when a positive decision is 
made, the two stimuli form a coherent semantic unit with the 
category label; thus, forming an effective memory cue for later 
recall. When a negative decision is made, the unit is more complex 
and may contain two category labels resulting in a less effective 
memory cue. The decision by response interaction found in the 
current study was also reported by Craik and Tulving (1975); 
however, there was no further elaboration presented in the article.
In the present study, subjects recalled significantly more words 
from physically identical decisions compared to same name 




Although DDAVP did not affect speed of accessing long-term 
memory in a clear and concise manner, the vasopressin analog does 
appear to facilitate cognitive processes involving simple detection 
of physical features once the motor component of the task and some 
of the cognitive processes involved in response selection and 
programming are removed. In attempting to relate these findings to 
the results of a previous study assessing the effects of DDAVP on 
recall of narrative prose (Beckwith et al., 1987), one might 
speculate that in the narrative prose situation the DDAVP-treated 
subject's detection of simple physical features is made more 
efficient; thus leaving more time for the more elaborate processing 
involved in the comprehension of a narrative prose passage. If, in 
fact, more time and attention were focused on the more elaborate 
processes, then a higher recall of more deeply processed information 
as shown by Beckwith et al. (1987) would be expected. These 
authors found that DDAVP facilitated recall of idea units within the 
passages of both high and medium levels of importance. DDAVP had 
no influence on recall of idea units at the low level of importance. 
The authors interpret these results as evidence that DDAVP "may 
have facilitated the divided attentional processes necessary to 
integrate text in working memory as evidenced by the increased 
attention to relevant as opposed to irrelevant details of the 
passages presented" (p.431). The present speculations are also 
consistent with this interpretation. Replication of the study with a
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simpler reaction time control task measuring the pure motor 
component of response time is warranted.
Additionally, analysis of the error rates suggests a subtle 
sexually dimorphic effect of the peptide analog. Again, this effect 
is not easily interpreted, but seems to suggest a facilitation in 
accuracy for DDAVP-treated female subjects, and an adverse effect 
in regard to error rates for DDAVP-treated male subjects. Sexually 
dimorphic effects appear likely in view of animal studies which 
report a sexually dimorphic effect of AVP on retention of a passive- 
avoidance response (Tinius et al., 1987; Swenson et al., 1990) and 
human studies reporting sexually dimorphic effects on human 
cognition (Beckwith et al., 1985; 1990).
Since all female subjects employed in the current study 
participated during the first five days of their menstrual cycles and 
were not taking oral contraceptives, the generalizability of the 
present findings are somewhat limited. It may be beneficial to 
focus further research efforts on various stages of the menstrual 
cycle, since the neurochemical substrate underlying the mechanisms 
of drug action have been found to vary across the menstrual cycle 
(Hamilton, 1986) and since cognitive and motor skills appear to be 
effected by normal physiological variations in gonadal hormones 
(Hampson, 1990).
In view of the clinical implications and previous studies 
reporting facilitative effects on memory, the subtle effects of 
DDAVP on accessing long-term memory deserve further research
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attention. Future research utilizing the category judgement task 
should include a simple reaction time task, which would give a truer 
estimate of the motor component of the task. In addition, possible 
sexually-dimorphic effects of the peptide analog have obvious 




Please answer the following questions carefully. All 
information provided will remain confidential. Your honest 
responses will determine your suitability for participation in 
research. If you wish you may leave answers blank, however this 
may preclude your participation in the study. Please estimate as 
accurately as possible when answering all questions. Feel free to 
add any comments you may have at any place on the questionnaire. If 
you indicate you are willing to participate, you will be called at a 
future date. Thank you for your participation.







Best times to reach by phone _________________________________
Please circle the most appropriate number on the line following each 
statem ent.
1. I drink coffee (If you answer "never," skip to question 4).
1 2 3 4 5 6 7
never less than at least 
one day one day 
a month a month
1-2 days 3-4 days 5-6 days da ily  
a week a week a week
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2. On days I drink coffee, I average
1 2 3 4 5 6 7
1 cup 2 cups 3-4 cups 5-6 cups 7-8 cups 9-10 cups > 10 
cups
3. I drink decaffeinated coffee
1 2 3 4 5 6 7















4. I drink beer (If you answer "never," skip to question 8).
1 2 3 4 5 6 7






1-2 days 3-4 days 5-6 days da ily  
a week a week a week
5. On days I drink beer, I average















6. On days I drink beer, I drink at least
















7. On days I drink beer, the most I drink is















8. I drink wine (If you answer "never," skip to question 12).
1 2 3 4 5 6 7










5-6 days da ily  
a week
9. On days I drink wine, I average















10. On days I drink wine, I drink at least















11. On days I drink wine, the most I drink is
















12. I drink alcoholic beverages other than beer and wine (e.g. scotch, 
vodka, rum, whiskey, etc.)
(If you answer "never," skip to question 16.)
1 2 3 4 5 6 7








3-4 days 5-6 days da ily  
a week a week
13. On days I drink alcoholic beverages other than 
average
beer or wine,









9 -1 0  >10 
drinks drinks
14. On days I drink alcoholic beverages other than 
drink at least
beer or wine, I









9 -1 0  >10 
drinks drinks
15. On days I drink 
drink at most
alcoholic beverages other than beer or wine, I
1 2 3 4 5 6 7
1 2 3 -4  5 -6  7 -8  9-1 0 >10
drink  drinks drinks drinks drinks drinks drinks
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16. I drink soda pop (cola, rootbeer, etc.)
1 2 3 4 5 6 7








3-4 days 5-6 days da ily  
a week a week
17. On days I drink soda pop, I average















18. I drink decaffeinated soda pop
1 2 3 4 5 6 7






1/2 the more than 






19. I smoke tobacco (e.g. cigarettes, pipe, cigars)
1 2 3 4 5 6 7








3-4 days 5-6 days da ily  
a week a week
20. On days I smoke, I average











9 -1 0  >10 
; smokes smokes
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21. I chew tobacco or snuff
1 2 3 4 5 6 7








3-4 days 5-6 days da ily  
a week a week
22. On days I chew, I average















23. I use a recreational drug which is not mentioned above
1 2 3 4 5 6 7








3-4 days 5-6 days da ily  
a week a week
24. My health in the! last year has been









Please answer the following questions ("yes" or "no"). If you answer 
"yes" to any question please describe when it occurred and any other 
relevant details.




26. Have you ever had allergies?
Yes_____________  Comments:_______________________________
No______________
27. Have you ever had ulcers?
Yes_____________  Comments:_______________________________
No______________
28. Have you ever had cardio-vascular disease?
Yes_____________  Comments:_______________________________
No______________
29. Have you ever had epilepsy?
Yes_____________  Comments:______________________________ _
No______________
30. Have you ever received treatment for overuse of alcohol or other 
drugs?
Yes_____________  Comments:____________________________ _
No______________
31. Are you currently taking any vitamins?
Yes______________No__________________
If yes, please list vitamins, reason for taking vitamins, and the 
length of time the vitamin has been taken.
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32. Are you currently taking any prescription medications?
Yes______________No__________________
If yes: a.) What is the name of the medication?
b. ) For what do you use the medication?
c. ) When did you start taking the medication?
33. Have you taken any prescription medications in the last five 
years that you are not currently taking?
Yes No
If yes: a.) What are the names of the medications?
b. ) Why did you take the medications?
c. ) When did you start taking the medications?
d. ) When did you stop taking the medications?
34. Are you currently taking over-the-counter medications 
(e.g., Vicks, Ni-Quil, antihistamines, etc.)?
Yes No
If yes: a. ) What is the name of the medication?
b. ) For what do you use the medication?
c. ) When did you start taking the medication?
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37. Would you be willing to participate in a study of the effects of 
vasopressin on memory?
Yes_______  No_____  Not sure at this time________________
FEMALES ONLY:
38. Are you currently pregnant?
Yes______________ No______________
39. Are you currently attempting to become pregnant?
Yes______________No__________________
40. Are you currently taking oral contraceptives?
Yes______________No__________________
41. If you are not currently taking oral contraceptives, have you 
ever taken oral contraceptives?
Yes______________No__________________





Physically Identical - Same
ORANGE 1 ORANGE 1
waterm elon 23 w aterm elon 23
bluejay 3 bluejay 3
nightgown 21 nightgown 21
cardinal 17.5 card ina l 17.
DRESSER 6.5 DRESSER 6.
FOOTBALL 1 FOOTBALL 1
toolbox 1 4 toolbox 1 4
wrench 23 wrench 23
HONDA 1 2 HONDA 1 2
AIRPLANE 1 8 AIRPLANE 1 8
sw itchb lade 6 sw itchb lade 6
BUREAU 1 4 BUREAU 1 4
shotgun 9 shotgun 9
SWEATSHIRT 1 1 SWEATSHIRT 1 1
VOLLEYBALL.. 14 VOLLEYBALL _ L 4






pants 1 autom obile 1
b u ffe t 30 ladder 24
BANANA 3 BLACKBIRD 6
van ity 21 sw im m ing 1 1
APPLE 2 TAXI 5.5
p lie rs 22 tomahawk 23
TENNIS 4 TANGERINE 6.5
underpants 1 2 tra ck 1 2
BUS 5.5 DAGGER 8
tra i le r 27 cabinet 27
kn ife 7 PARAKEET 1 0
ARROW 25 LAMP 31
d r i l l 5 nectarine 1 0
DOVE 7 SCREWDRIVER 4
REDBIRD 13.5 SLACKS 7
hockey_____ 9 iacket __a
sum=194 sum1=194
X-12.1 X=12.1
Same Name - Same
GRAPEFRUIT 1 2 g ra p e fru it 1 2
ORIOLE 1 1 orio le 1 1
basketball 3 BASKETBALL 3
BOXING 1 3 boxing 1 3
APRICOT 6.5 ap rico t 6.5
eagle 17.5 EAGLE 17.5
couch 3.5 COUCH 3.5
boat 20 BOAT 20
table 3.5 TABLE 3.5
JET 21 je t 21
PAJAMAS 1 8 pajamas 1 8
PARKA 1 7 parka 1 7
club 1 9 CLUB 1 9
RIFLE 5 r i f le 5
level 1 1 LEVEL 1 1
fils_________ ____ 13 FILE 1 3
sum = 194 sum = 194
X=12.1 X=12.1
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Same Name - Different
SPARROW 2 dress 2.5
mockingbird 1 2 BERRY 1 3
RULER 3 revo lver 3
bench 21 POLO 1 8
handball 7 JEEP 7
GOLF 1 7 fo o ts to o l 26
PISTOL 2 robin 1
ambulance 8 CANOEING 6
bicycle 1 6 BLUEBERRY 1 8
MELON 1 7 chest 1 9
CHERRY 1 4 panties 14.5
bazooka 1 6 CARRIAGE 1 7
divan 1 7 PENCIL 1 8
ottoman 25 CANNON 1 7
SHIRT 2.5 nails 6
JUMPER 14.5 lark 8
sum = 194 sum1=194
X=12.1 X=12.1
Same Category - Same
CHAIR 1.5 SOFA 1.5
CRICKET 22.5 SQUASH 22.5
tru ck 3 car 4
HUMMINGBIRD 1 9 PIGEON 22
bluebird 4 CANARY 5
w re s tlin g 20 surfing 1 9
SUIT 6 blouse 5
OVERCOAT 20 undersh irt 1 9
sword 1 0 BOMB 11.5
spear 1 5 BAYONET 13.5
van 1 1 s tre e tca r 1 0
DESK 1 2 BED 1 3
PLUM 8 grapes 9
BLACKBERRY 1 6 pineapple 1 5
sandpaper 9 sawhorse 8
RASP________ 1 7 chisel 1 6
sum = 194 sum = 194
X= 12.1 X=12.1
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Same Category - Different
GUN 1 SAW 1
MORTAR 24 lounge 23
hammer 2 baseball 2
bookcase 22 BULLET 22
PEACH 4 SKIRT 4
LEMON 20 LANCE 20
bike 1 9 hacksaw 1 9
s o ftb a ll 5 PEAR 5
rugby 8 coat 9
socks 1 6 STARLING 1 6
sw eater 1 0 rocker 9
FINCH 1 5 lacrosse 1 5
WREN 13.5 tro lle y 1 5
SANDER 1 0 STRAWBERRY 1 1
m otorcycle 9 SWALLOW 9
davenport 15.5 TRAIN 1 4





CHAIR 1.5 CHAIR 1
CRICKET 22.5 CRICKET 22
TRUCK 3 TRUCK 3
hum m ingb ird 1 9 h um m ingb ird 1 9
b lu e b ird 4 b lu e b ird 4
WRESTLING 20 WRESTLING 20
s u i t 6 s u i t 6
OVERCOAT 20 OVERCOAT 20
sw o rd 1 0 sw o rd 1 0
spear 1 5 spear 1 5
VAN 1 1 VAN 1 1
DESK 1 2 DESK 1 2
PLUM 8 PLUM 8
b la c k b e rry 1 6 b la c k b e rry 1 6
sandpaper 9 sandpaper 9
rasD 1 7 rasD 1 7
sum = 194 sum = 194
X=12.1 X=12.1
P hys ica lly  Id e n t ica l-D if fe re n t
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GUN 1 SAW 1
MORTAR 24 LOUNGE 23
hammer 2 baseball 2
bookcase 22 b u lle t 22
PEACH 4 SKIRT 4
LEMON 20 LAJMCE 20
bike 1 9 hacksaw 1 0
s o ftb a ll 5 pear 5
RUGBY 8 COAT 9
socks 1 6 s ta rlin g 1 6
sw eater 1 0 rocker 9
FINCH 1 5 LACROSSE 1 5
WREN 13.5 TROLLEY 1 5
sander 1 0 s traw b erry 1 1
MOTORCYCLE 9 SWALLOW 9
davenDort 15.5 train 1 4
sumi = 194 sum1=194
X=12.1 X=12.1
Same Name-Same
SOFA 1.5 sofa 1.5
SQUASH 22.5 squash 22.5
car 4 CAR 4
PIGEON 22 pigeon 22
CANARY 5 canary 5
surfing 1 9 SURFING 1 9
BLOUSE 5 blouse 5
undershirt 1 9 UNDERSHIRT 1 9
BOMB 11.5 bomb 11.5
bayonet 13.5 BAYONET 13.5
s tre e tca r 1 0 STREETCAR 1 0
BED 1 3 bed 1 3
GRAPES 9 grapes 9
pineapple 1 5 PINEAPPLE 1 5
sawhorse 8 SAWHORSE 8
CHISEL 16 chisel 1 6




pants 1 AUTOMOBILE 1
BUFFET 30 ladder 24
BANANA 3 blackbird 6
van ity 21 SWIMMING 1 1
apple 2 TAXI 5.5
PLIERS 22 tomahawk 23
TENNIS 4 tangerine 6.5
UNDERPANTS 1 2 TRACK 1 2
BUS 5.5 dagger 8
t ra i le r 27 CABINET 27
kn ife 7 PARAKEET 1 0
ARROW 25 lamp 31
d r i l l 5 NECTARINE 1 0
dove 7 screw drive r 4
REDBIRD 13.5 slacks 7
hockev 9 JACKET 8
sumi = 194 sumi=194
X=12.1 X=12.1
Same Category-Same
orange 2 APRICOT 6.5
waterm elon 23 GRAPEFRUIT 1 2
BLUEJAY 3 orio le 1 1
NIGHTGOWN 21 pajamas 1 8
cardinal 17.5 eagle 17.5
dresser 6.5 couch 3.5
FOOTBALL 1 BASKETBALL 3
toolbox 1 4 level 1 1
wrench 23 f i le 1 3
HONDA 1 2 BOAT 20
airplane 1 8 je t 21
SWITCHBLADE 6 RIFLE 5
BUREAU 1 4 TABLE 3.5
shotgun 9 CLUB 1 9
SWEATSHIRT 1 1 PARKA 1 7
VOLLEYBALL 1 4 boxina 1 3
sum = 194 sum = 194
X=12.1 X=12.1
78
Same C ategory-D iffe ren t
sparrow 2 DRESS 2.5
MOCKINGBIRD 1 2 BERRY 1 3
ru le r 3 revo lver 3
bench 21 polo 1 8
handball 7 JEEP 7
GOLF 1 7 FOOTSTOOL 26
BAZOOKA 1 6 carriage 1 7
PISTOL 2 robin 1
AMBULANCE 8 canoeing 6
bicycle 1 6 blueberry 1 8
melon 1 7 CHEST 1 9
CHERRY 1 4 PANTIES 14.5
divan 1 7 PENCIL 1 8
ottoman 25 CANNON 1 7
SHIRT 2.5 nails 6
JUMPER 14.5 lark 8





SOFA 1.5 SOFA 1.5
SQUASH 22.5 SQUASH 22.5
car 4 car 4
pigeon 22 pigeon 22
canary 5 canary 5
surfing 1 9 surfing 1 9
BLOUSE 5 BLOUSE 5
undershirt 1 9 undersh irt 1 9
bomb 11.5 bomb 11.5
bayonet 13.5 bayonet 13.5
s tre e tca r 1 0 s tre e tca r 1 0
BED 1 3 BED 1 3
GRAPES 9 GRAPES 9
PINEAPPLE 1 5 PINEAPPLE 1 5
SAWHORSE 8 SAWHORSE 8
CHISEL 16 CHISEL 1 6
sum = 194 
X=12.1
sum = 194 
X=12.1
P hys ica lly  Id e n t ic a l-D if fe re n t
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SPARROW 2 DRESS 2.5
MOCKINGBIRD 1 2 BERRY 1 3
RULER 3 REVOLVER 3
bench 21 polo 1 8
HANDBALL 7 JEEP 7
g o lf 1 7 fo o ts to o l 26
BAZOOKA 1 6 CARRIAGE 1 7
p is to l 2 robin 1
ambulance 8 canoeing 6
bicycle 1 6 blueberry 1 8
MELON 1 7 CHEST 1 9
cherry 1 4 panties 14.5
DIVAN 1 7 PENCIL 1 8
OTTOMAN 25 CANNON 1 7
s h ir t 2.5 na ils 6
iumDer 14.5 lark _ a
sum = 194 sum = 194
X-12.1 X=12.1
Same Name-Same
cha ir 1.5 CHAIR 1.5
c r ic k e t 22.5 CRICKET 22.5
tru ck 3 TRUCK 3
hummingbird 1 9 HUMMINGBIRD 1 9
bluebird 4 BLUEBIRD 4
WRESTLING 20 w re s tlin g 20
SUIT 6 s u it 6
OVERCOAT 20 overcoat 20
sword 1 0 SWORD 1 0
SPEAR 1 5 spear 1 5
van 1 1 VAN 1 1
DESK 1 2 desk 1 2
plum 8 PLUM 8
BLACKBERRY 1 6 blackberry 1 6
sandpaper 9 SANDPAPER 9







GUN 1 saw 1
m ortar 24 LOUNGE 23
hammer 2 BASEBALL 2
BOOKCASE 22 b u lle t 22
peach 4 SKIRT 4
lemon 20 LANCE 20
bike 1 9 HACKSAW 1 9
SOFTBALL 5 pear 5
RUGBY 8 coat 9
SOCKS 1 6 s ta rlin g 1 6
sw eater 1 0 ROCKER 9
finch 1 5 LACROSSE 1 5
WREN 13.5 tro lle y 1 5
sander 1 0 STRAWBERRY 1 1
MOTORCYCLE 9 sw a llo w 9
DAVENPORT 15.5 train 1 4
sumi = 194 sum1 = 194
X=12.1 X=12.
Same Category-Same
APRICOT 6.5 orange 1
GRAPEFRUIT 1 2 waterm elon 23
orio le 1 1 BLUEJAY 3
PAJAMAS 1 8 nightgown 21
EAGLE 17.5 CARDINAL 17.
COUCH 3.5 DRESSER 6.
BASKETBALL 3 FOOTBALL 1
LEVEL 1 1 toolbox 1 4
f i le 1 3 wrench 23
boat 20 honda 1 2
je t 21 airplane 1 8
r i f le 5 SWITCHBLADE 6
TABLE 3.5 BUREAU 1 4
club 1 9 SHOTGUN 9
PARKA 1 7 s w e a ts h irt 1 1
boxina 13 vollevball 1 4
sum = 194 sum = 194
X-12.1 X=12.
Same C ategory-D iffe ren t
82
pants 1 autom obile 1
b u ffe t 30 LADDER 24
BANANA 3 BLACKBIRD 6
van ity 21 SWIMMING 1 1
APPLE 2 TAXI 5,
PLIERS 22 TOMAHAWK 23
tennis 4 tangerine 6.
underpants 1 2 TRACK 1 2
bus 5.5 DAGGER 8
tra i le r 27 cabinet 27
KNIFE 7 parakeet 1 0
ARROW 5 LAMP 31
d r i l l 5 nectarine 1 0
DOVE 7 screw drive r 4
REDBIRD 13.5 slacks 7






PANTS 1 PANTS 1
b u ffe t 30 b u ffe t 30
banana 3 banana 3
van ity 1 van ity 21
APPLE 2 APPLE 2
p lie rs 22 p lie rs 22
TENNIS 4 TENNIS 4
underpants 1 2 underpants 1 2
BUS 5.5 BUS 5.5
t ra i le r 27 t ra i le r 27
KNIFE 7 KNIFE 7
arrow 25 arrow 25
DRILL 5 DRILL 5
DOVE 7 DOVE 7
REDBIRD 13.5 REDBIRD 13.5
HOCKEY 9 HOCKEY 9
sum = 194 
X=12.1
sum = 194 
X=12.1
P hys ica lly  Id e n t ic a l-D if fe re n t
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VOLLEYBALL 1 4 NECTARINE 1 0
sw e a tsh irt 1 1 dagger 8
SHOTGUN 9 SLACKS 7
bureau 1 4 sw im m ing 1 1
sw itchblade 6 blackbird 6
AIRPLANE 1 8 TOMAHAWK 23
honda 1 2 ja c k e t 8
WRENCH 23 LAMP 31
toolbox 1 4 parakeet 1 0
fo o tb a ll 1 screw drive r 4
DRESSER 6.5 TANGERINE 6.
cardinal 17.5 tra ck 1 2
NIGHTGOWN 21 LADDER 24
BLUEJAY 3 TAXI 5.
WATERMELON 23 CABINET 27
oranae 1 automobile 1
sumi = 194 sum1=194
X=12.1 X=12
Same Name-Same
SPARROW 2 sparrow 2
mockingbird 1 2 MOCKINGBIRD 1 2
RULER 3 ru le r 3
bench 21 BENCH 21
handball 7 HANDBALL 7
GOLF 1 7 g o lf 1 7
bazooka 1 6 BAZOOKA 1 6
PISTOL 2 p is to l 2
ambulance 8 AMBULANCE 8
BICYCLE 1 6 bicycle 1 6
melon 1 7 MELON 1 7
CHERRY 1 4 cherry 1 4
DIVAN 1 7 divan 1 7
ottoman 25 OTTOMAN 25
s h ir t 2.5 SHIRT 2.
JUMPER 14.5 iumDer 14.
sum = 194 sum = 194
X=12.5 X=12.
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Same Nam e-D ifferent
g ra p e fru it 1 2 PANTIES 14.5
orio le 1 1 JEEP 7
BASKETBALL 3 ROBIN 1
BOXING 1 3 berry 1 3
APRICOT 6.5 na ils 6
EAGLE 17.5 polo 1 8
couch 3.5 DRESS 2.5
BOAT 20 chest 1 9
TABLE 3.5 revo lver 3
je t 21 FOOTSTOOL 26
pajamas 1 8 PENCIL 1 8
PARKA 1 7 carriage 1 7
club 1 9 blueberry 1 8
r i f le 5 CANOEING 6
level 1 1 LARK 8
FILE 13 cannon 1 7
sumi = 194 sum1 = 194
X=12.5 X=12.5
Same Category-Same
gun 1 lance 20
MORTAR 24 b u lle t 22
hammer 2 SAW 1
bookcase 22 lounge 23
peach 4 pear 5
lemon 20 s traw b erry 1 1
bike 1 9 TROLLEY 1 5
SOFTBALL 5 BASEBALL 2
RUGBY 8 lacrosse 1 5
socks 1 6 coat 9
SWEATER 1 0 SKIRT 4
FINCH 1 5 STARLING 1 6
WREN 13.5 SWALLOW 9
sander 1 0 HACKSAW 1 9
m otorcycle 9 TRAIN 1 4
DAVENPORT 15.5 ROCKER 9
sum = 194 sum = 194
X=12.5 X=12.5
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Same C ategory-D iffe ren t
cha ir 1.5 car 4
CRICKET 22.5 undershirt 1 9
TRUCK 3 sofa 1.5
HUMMINGBIRD 1 9 surfing 1 9
BLUEBIRD 4 BLOUSE 5
w re s tlin g 20 pigeon 22
s u it 6 CANARY 5
overcoat 20 SQUASH 22.5
SWORD 1 0 s tre e tca r 1 0
SPEAR 1 5 chise l 1 6
VAN 1 1 BOMB 11.5
desk 1 2 bayonet 13.5
PLUM 8 sawhorse 8
BLACKBERRY 1 6 BED 1 3
sandpaper 9 GRAPES 9
rasp 1 7 PINEAPPLE 15
sum = 194 
X=12.5





GUN 1 GUN 1
m ortar 24 m orta r 24
hammer 2 hammer 2
bookcase 22 bookcase 22
peach 4 peach 4
LEMON 20 LEMON 20
BIKE 1 9 BIKE 1 9
SOFTBALL 5 SOFTBALL 5
rugby 8 rugby 8
socks 1 6 socks 1 6
SWEATER 1 0 SWEATER 1 0
finch 1 5 finch 1 5
WREN 13.5 WREN 13.5
sander 1 0 sander 1 0
MOTORCYCLE 9 MOTORCYCLE 9
DAVENPORT 15.5 DAVENPORT 15.5
sum = 194 sum = 194
X=12.5 X=12.5
P h ys ica lly  Id e n tic a l-D iffe re n t
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cha ir 1.5 car 4
c ric k e t 22.5 undersh irt 1 9
TRUCK 3 SOFA 1.5
HUMMINGBIRD 1 9 SURFING 1 9
BLUEBIRD 4 BLOUSE 5
WRESTLING 20 PIGEON 22
s u it 6 canary 5
overcoat 20 squash 22.5
SWORD 1 0 STREETCAR 1 0
SPEAR 1 5 CHISEL 1 6
van 1 1 bomb 11.5
desk 1 2 bayonet 13.5
PLUM 8 SAWHORSE 8
blackberry 1 6 bed 1 3
SANDPAPER 9 GRAPES 9
rasD 7 oineaDDle 1 5
surr1 = 194 sum=194
X=12.5 X=12.5
Same Name-Same
LANCE 20 lance 20
b u lle t 22 BULLET 22
SAW 1 saw 1
lounge 23 LOUNGE 23
pear 5 PEAR 5
STRAWBERRY 1 1 s traw b erry 1 1
TROLLEY 1 5 tro lle y 1 5
BASEBALL 2 baseball 2
lacrosse 1 5 LACROSSE 1 5
COAT 9 coat 9
SKIRT 4 s k ir t 4
s ta rlin g 1 6 STARLING 1 6
sw a llo w 9 SWALLOW 9
hacksaw 1 6 HACKSAW 1 6
tra in 1 4 TRAIN 1 4
ROCKER 9 rocker 9
sum = 194 sum = 194
X=12.5 X=12.5
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Same N am e-D iffe ren t
vo lleyb a ll 1 4 NECTARINE 1 0
SWEATSHIRT 1 1 dagger 8
SHOTGUN 9 slacks 7
bureau 1 4 SWIMMING 1 1
SWITCHBLADE 6 blackbird 6
airplane 1 8 TOMAHAWK 23
HONDA 1 2 ja c k e t 8
WRENCH 23 lamp 31
toolbox 1 4 PARAKEET 1 0
fo o tb a ll 1 SCREWDRIVER 4
DRESSER 6.5 tangerine 6.5
CARDINAL 17.5 tra ck 1 2
nightgown 21 LADDER 24
bluejay 3 TAXI 5.5
waterm elon 23 CABINET 27
ORANGE 1 autom obile 1
sumi=194 sumi = 194
X=12.5 X=12.5
Same Category-Same
HOCKEY 9 g o lf 1 7
redbird 13.5 mockingbird 1 2
DOVE 7 SPARROW 2
d r i l l 5 RULER 3
arrow 25 bazooka 1 6
KNIFE 7 PISTOL 2
tra i le r 27 BICYCLE 1 6
BUS 5.5 AMBULANCE 8
UNDERPANTS 1 2 jum per 14.5
TENNIS 4 handball 7
PLIERS 22 BENCH 21
apple 2 cherry 1 4
van ity 21 divan 1 7
banana 3 OTTOMAN 25
pants 1 SHIRT 2.5
buffet 30 MELON 1 7
sum = 194 sum = 194
X=12.5 X-12.5
Sam e C a te gory-D iffe ren t
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GRAPEFRUIT 1 2 PANTIES 14.5
ORIOLE 1 1 JEEP 7
basketball 3 robin 1
boxing 1 3 BERRY 1 3
APRICOT 6.5 na ils 6
eagle 17.5 polo 1 8
COUCH 3.5 dress 2.5
BOAT 20 CHEST 1 9
table 3.5 revo lver 3
JET 21 FOOTSTOOL 26
PAJAMAS 1 8 pencil 1 8
PARKA 1 7 carriage 1 7
club 1 9 blueberry 1 8
RIFLE 5 canoeing 6
level 1 1 LARK 8
file 13 CANNON 1 7





LANCE 20 LANCE 20
b u lle t 22 b u lle t 22
saw 1 saw 1
LOUNGE 23 LOUNGE 23
PEAR 5 PEAR 5
straw b erry 1 1 s traw b erry 1 1
tro lle y 1 5 tro lle y 1 5
BASEBALL 2 BASEBALL 2
lacrosse 1 5 lacrosse 1 5
coat 9 coat 9
SKIRT 4 SKIRT 4
s ta rlin g 1 6 s ta rlin g 1 6
SWALLOW 9 SWALLOW 9
HACKSAW 1 9 HACKSAW 1 9
TRAIN 1 4 TRAIN 1 4
rocker 9 rocker ___a
sum=194 
X=12.5
sum = 194 
X=12.5
P h ys ica lly  Id e n tic a l-D iffe re n t
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GRAPEFRUIT 1 2 PANTIES 14.5
ORIOLE 1 1 JEEP 7
BASKETBALL 3 ROBIN 1
boxing 1 3 berry 1 3
APRICOT 6.5 NAILS 6
eagle 17.5 polo 1 8
COUCH 3.5 DRESS 2.5
BOAT 20 CHEST 1 9
table 3.5 revolver 3
je t 21 fo o ts to o l 26
PAJAMAS 1 8 PENCIL 1 8
PARKA 1 7 CARRIAGE 1 7
club 1 9 blueberry 1 8
r i f le 5 canoeing 6
level 1 1 la rk 8
file 1 3 cannon 1 7
surri = 194 surr1=194
X=12.5 X=12.5
Same Name-Same
gun 1 GUN 1
MORTAR 24 m ortar 24
HAMMER 2 hammer 2
BOOKCASE 22 bookcase 22
PEACH 4 peach 4
lemon 20 LEMON 20
BIKE 1 9 bike 1 9
SOFTBALL 5 s o ftb a ll 5
rugby 8 RUGBY 8
socks 1 6 SOCKS 1 6
SWEATER 1 0 sw eater 1 0
finch 1 5 FINCH 1 5
wren 13.5 WREN 13.5
sander 1 0 SANDER 1 0
MOTORCYCLE 9 m otorcycle 9
davenDort 15.5 DAVENPORT 15.5
sum = 194 sum = 194
X=12.5 X=12.5
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Same N am e-D iffe ren t
CHAIR































































sum = 194 sum=194
X=12.5 X=12.5
Same Category-Same
PANTS 1 s h ir t 2.5
BUFFET 30 ottoman 25
BANANA 3 melon 1 7
van ity 21 divan 1 7
APPLE 2 BENCH 21
TENNIS 4 HANDBALL 7
underpants 1 2 JUMPER 14.5
bus 5.5 AMBULANCE 8
TRAILER 27 bicycle 1 6
kn ife 7 p is to l 2
arrow 25 bazooka 1 6
d r i l l 5 ru le r 3
DOVE 7 SPARROW 2
REDBIRD 13.5 MOCKINGBIRD 1 2
hockey 9 GOLF 1 7
Dliers 22 cherry 1 4
sum:= 194 sum = 194
X=12.5 X=12.5
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Sam e C a te gory-D iffe ren t
vo lleyb a ll 1 4 nectarine 1 0
sw e a tsh irt 1 1 DAGGER 8
SHOTGUN 9 SLACKS 7
BUREAU 1 4 sw im m ing 1 1
SWITCHBLADE 6 BLACKBIRD 6
AIRPLANE 1 8 TOMAHAWK 23
honda 1 2 ja c k e t 8
WRENCH 23 LAMP 31
toolbox 1 4 PARAKEET 1 0
fo o tb a ll 1 screw drive r 4
dresser 6.5 tangerine 6.
CARDINAL 17.5 TRACK 1 2
nightgown 21 LADDER 24
BLUEJAY 3 ta x i 5.
WATERMELON 23 cabinet 27
oranae 1 automobile 1




Information About and Consent for participation in Study Entitled: 
Effects of Vasopressin on the Category Judgement
The purpose of this study is to examine the effects of 
vasopressin on cognitive functioning (i.e. memory) in healthy college 
students. You have been chosen to participate in this study based on 
your responses to the screening questionnaire, which you completed 
earlier this semester. Your participation is voluntary. You will be 
asked to inhale a normal therapeutic dose (60 micrograms) of 
vasopressin (desmopressin acetate or DDAVP). Vasopressin or 
antidiuretic hormone (ADH) is normally present in the human body, 
causing the kidneys to concentrate your urine output. The dose of 
vasopressin you will receive will concentrate your urine to a degree 
similar to what you experience following a period of limited fluid 
intake (for example, the urine you pass after a long night's sleep). 
Because of this effect, you are advised to limit your liquid intake to 
no more than twelve 8 ounce glasses of liquid in the twenty-four 
hour period following administration of vasopressin.
We will ask your permission to measure your blood pressure 
prior to hormonal administration. Following this measurement, you 
will be asked to practice a computer task. Following the practice 
trials, you will be asked to inhale a small amount of fluid through 
your nose and to wait 20 minutes for the hormone to be absorbed. 
Upon completion of the absorption period, you will again be asked to 
complete several computer tasks. The total time required for this 
experiment is two hours.
DDAVP has been known to produce transient headache and 
nausea in some individuals when administered in high doses, but this 
is an infrequent effect and the dose used in this study is not high. 
DDAVP may also produce a slight elevation in blood pressure which 
is also an infrequent effect. Potential benefits from this study 
include information regarding the effect of vasopressin on cognitive 
processes in humans. We hope to obtain results supporting the 
usefulness of this hormone for improving memory processes in 
humans. In order to insure unbiased results, you will be assigned to 
either a treatment group or a placebo group.
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All information obtained in connection with this study will 
remain confidential and will be disclosed only with your permission. 
Your decision whether or not to participate in this experiment will 
not prejudice your future relations with UND or the Psychology 
Department. If you decide to participate, you are free to discontinue 
participation at any time without prejudice. If you do not wish to 
participate, you are not required to enter into this research.
The investigators will be available to answer any questions 
that you may have regarding this study. In addition, you are 
encouraged to ask questions that occur to you in the future.
Questions may be answered by either Robyn Swenson (777-3691) or 
Dr. Bill Beckwith (777-3451), or Dr. Rolf Paulson (780-6000). In the 
event of damage or injury resulting from this study, medical 
treatment will be available as it is to any member of the general 
public in similar circumstances. Payment for any such treatment 
must be provided by you or your third party payor. You will be given 
a copy of this form.
I have read all of the above and willingly agree to participate 
in this study as explained to me by
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Signature Date
Witness (other than scientist) Date
APPENDIX D
SOURCE OF VARIANCE TABLES
Table 11
Analy.si5_.Qf Variance Table for Age
SOURCE SS DF MS F P
Treatm ent 5.652 1 5.652 0.101 >0.500
Gender 143.841 1 143.841 2.566 0.114
Treatment X Gender 86.903 1 86.903 1.550 0.217
Unit 4484.109 80 56.051 Not Tested
Total 4720.500 83 56.873
Table 12
Analysis of Variance Table for WAIS-R Vocabulary Test fRaw Scorel
SOURCE SS DF MS F P
Treatm ent 172.862 1 172.862 0.431 >0.500
Gender 656.942 1 656.942 1.639 0.205
Treatment X Gender 0.159 1 0.159 Very Small
Unit 31656.773 79 400.719 Not Tested
Total 32486.730 82 396.180
Table 13
Analysis of Variance Table for Diastolic Blood Pressure
SOURCE SS DF MS F P
T reatm ent 174.959 1 174.959 0.483 0.490
Gender 795.662 1 795.662 2.197 0.143
Treatment X Gender 17.611 1 17.611 0.049 >0.500
Unit 28612.500 79 362.183 Not Tested




Analysis of Variance Table for Systolic Blood Pressure
SOURCE SS DF MS F P
Treatm ent 168.358 1 168.358 0.313 >0.500
Gender 17275.113 1 17275.11
3
32.126 <0.001
Treatment X Gender 12.200 1 12.200 0.023 >0.500
Unit 42480.000 79 537.721 Not Tested
Total 59935.668 82 730.923
Table 15
Analysis of Variance Table for Self-reported Weight
SOURCE SS DF MS F P
Treatm ent 248.57 1 248.570 0.087 >0.500
Gender 157840.81 1 157840.81
3
55.231 <0.001
Treatment X Gender 3544.46 1 3544.456 1.240 0.269
Unit 222909.75 78 2857.817 Not
Tested
Total 384543.56 81 1043.748
Table 16
Analysis of Variance Table for Dav of Menstrual Cycle
SOURCE SS DF MS F P
Treatm ent 11.040 1 11.040 1.138 0.293
Unit 378.231 39 9.698 Not Tested
Total 389.271 40 9.732
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Table 17
Analysis of Variance Table for Transform ed Median Response Times
SOURCE SS DF MS F
T reatm ent 0.001 1 0.001 0.038 >0.500
Gender 0.009 1 0.009 0.245 >0.500
Treatment X Gender 0.002 1 0.002 0.061 >0.500
Unit 2.855 80 0.036 Not Tested
Decision 6.269 2 3.134 870.803 <0.001
Treatment X 
Decision
0.015 2 0.008 2.120 0.124
Gender X Decision 0.004 2 0.002 0.498 >0.500
Treatment X Gender 
X Decision
0.006 2 0.003 0.861 0.425
Decision X Unit 0.576 1 60 0.004 Not Tested
Response 0.110 1 0.110 75.972 <0.001
Treatment X 
Response
0.002 1 0.002 1.428 0.236
Gender X Response 0.002 1 0.002 1.069 0.305
Treatment X Gender 
X Response
0.001 1 0.001 0.478 0.492
Response X Unit 0.116 80 0.001 Not Tested
Decision X 
Response




0.003 2 0.001 1.042 0.356
Gender X Decision X 
Response
0.002 2 0.001 0.706 0.496
Treatment X Gender 
X Decision X 
Response
0.000 2 0.000 0.019 >0.500
Decision X 
Response X Unit
0.229 1 60 0.001 Not Tested
Tota l 10.251 503 0.020
Table 18
Analysis of Variance Table for Transformed Median Response Time 
Controls
SOURCE SS DF MS F p
Treatm ent 0.021 1 0.021 2.409 0.125
Gender 0.024 1 0.024 2.795 0.099
Treatment X Gender 0.002 1 0.002 0.230 >0.500
Unit 0.681 80 0.009 Net Tested
Response 0.006 1 0.006 9.857 0.003
Treatment X 
Response
0.004 1 0.004 6.731 0.012
Gender X Response 0.000 1 0.000 0.005 >0.500
Treatment X Gender 
X Response
0.000 1 0.000 0.011 >0.500
Response X Unit 0.052 80 0.001 Not Tested
Total 0.790 167 0.005
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Table 19
Analysis of Variance Table for Transform ed D ifference Scores
SOURCE SS DF MS F
Treatm ent 0.015 1 0.084 0.221 >0.500
Gender 0.084 1 0.084 1.258 0.266
Treatment X Gender 0.011 1 0.011 0.170 >0.500
Unit 5.357 80 0.067 Not Tested
Decision 12.559 2 6.280 821.517 <0.001
Treatment X 
Decision
0.049 2 0.024 3.197 0.044
Gender X Decision 0.016 2 0.008 1.047 0.354
Treatment X Gender 
X Decision
0.016 2 0.008 1.039 0.357
Decision X Unit 1.223 1 60 0.008 Not Tested
Response 0.309 1 0.309 73.906 <0.001
Treatment X 
Response
0.000 1 0.000 Very Small
Gender X Response 0.001 1 0.001 0.326 >0.500
Treatment X Gender 
X Response
0.001 1 0.001 0.241 >0.500
Response X Unit 0.334 80 0.004 Not Tested
Decision X 
Response




0.004 2 0.002 0.569 >0.500
Gender X Decision X 
Response
0.005 2 0.002 0.744 0.477
Treatment X Gender 
X Decision X 
Response
0.000 2 0.000 0.017 >0.500
Decision X 
Response X Unit
0.509 1 60 0.003 Not Tested
Total 20.550 503 0.041
Table 20
Analysis of Variance Table for Transform ed Error Rates
SOURCE_______________ SS DF MS_________ F____________p
Treatm ent 0.000 1 0.000 0.005 >0.500
Gender 0.000 1 0.000 0.007 >0.500
Treatment X Gender 0.281 1 0.281 5.632 0.021
Unit 3.997 80 0.050 Not Tested
Decision 3.166 2 1.583 68.578 <0.001
Treatment X 
Decision
0.067 2 0.034 1.452 0.238
Gender X Decision 0.301 2 0.150 6.510 0.002
Treatment X Gender 
X Decision
0.003 2 0.002 0.067 >0.500
Decision X Unit 3.693 1 60 0.023 Not Tested
Response 0.002 1 0.002 0.090 >0.500
Treatment X 
Response
0.172 1 0.172 7.166 0.010
Gender X Response 0.009 1 0.009 0.384 >0.500
Treatment X Gender 
X Response
0.016 1 0.016 0.666 0.418
Response X Unit 1.917 80 0.024 Not Tested
Decision X 
Response




0.015 2 0.008 0.369 >0.500
Gender X Decision X 
Response
0.013 2 0.007 0.321 >0.500
Treatment X Gender 
X Decision X 
Response
0.089 2 0.045 2.160 0.119
Decision X 
Response X Unit
3.304 1 60 0.021 Not Tested
T otal 17.201 503 0.034
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Table 21
Analysis of Variance Table for Transform ed Proportion Recall
SOURCE SS DF MS F
Treatm ent 0.034 1 0.034 1.158 0.286
Gender 0.001 1 0.001 0.029 >0.500
Treatment X Gender 0.037 1 0.037 1.268 0.264
Unit 2.325 79 0.029 Not Tested
Decision 1.311 2 0.656 39.913 <0.001
Treatment X 
Decision
0.093 2 0.047 2.839 0.062
Gender X Decision 0.018 2 0.009 0.563 >0.500
Treatment X Gender 
X Decision
0.037 2 0.019 1.129 0.326
Decision X Unit 2.595 1 58 0.016 Not Tested
Response 1.728 1 1.728 100.610 <0.001
Treatment X 
Response
0.000 1 0.000 0.004 >0.500
Gender X Response 0.000 1 0.000 Very Small
Treatment X Gender 
X Response
0.000 1 0.000 0.018 >0.500
Response X Unit 1.357 79 0.017 Not Tested
Decision X 
Response




0.050 2 0.025 1.884 0.156
Gender X Decision X 
Response
0.024 2 0.012 0.895 0.411
Treatment X Gender 
X Decision X 
Response
0.002 2 0.001 0.086 >0.500
Decision X 
Response X Unit
2.102 1 58 0.013 Not Tested
Total 11.802 497 0.024
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